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Abstract 
Canada’s growing population of older people with MS (PwMS) has warranted a 
closer look into factors associated with depression that may interfere with healthy aging. 
At the same time, researchers, clinicians, and medical professionals treating PwMS with 
mood disorders have spoken about the difficulty they face when having to determine a 
diagnosis of depression in this population. This difficulty arises because both MS and 
depression share various psychological and neurological symptoms (e.g., fatigue, pain, 
sleep difficulties, psychomotor retardation, and cognitive difficulties). It is also found that 
these overlapped symptoms vary when completing a self-report measure of depression, 
versus when medically diagnosed by a psychiatrist. As such, we aim to investigate the 
personal and disease-related factors that are associated with self-reported depressive 
symptoms and medically diagnosed depression (i.e. depression diagnosed by a medical 
professional). Following this, we aim to determine the risk factors for depression in older 
PwMS.   
This study used secondary data collected from the original study, the Canadian 
survey of health, lifestyle, and aging with multiple sclerosis. Data of the original study 
was collected from 743 Canadians (> 55 years of age and living with MS for >20 years). 
In this present study, presence of self-reported depressive symptoms was defined as a 
score of ≥ 8 on the depression component of the Hospital Anxiety and Depression Scale 
(HADS-D). Presence of medically diagnosed depression was determined by the item that 
asked participants if they have received a diagnosis of depression by their medical 
professional. Logistic regression was used to identify variables that predicted depression.  
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Self-reported depressive symptoms were found in 30.5% of the population, while 
medically diagnosed depression was found in 25.7%. 11.7% of PwMS had both self-
identified depressive symptoms and were diagnosed with depression by their medical 
professional. Low social support, high perceived disability, and additional comorbid 
physical conditions were independent predictors of depression in older PwMS in our 
cohort.  
Depression is prevalent in older PwMS. Clinicians should be cognizant of the 
overlap of symptoms between MS and depression and should employ possible ways to 
minimize over-diagnosing or underdiagnosing depression in this population. Identifying 
risk factors for depression is imperative because at-risk individuals may be thoroughly 
assessed for depression and will be able to receive treatment more promptly.  
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Chapter 1 
1.1 Statement of the Problem 
The almost irrefutable hypothesis that people with chronic diseases are more 
vulnerable to depression continues to grow in popularity (Gunn, Diggens, Hegarty, & 
Blashki 2006; Huang, Dong, Lu, Yue, & Liu, 2010; Katon, 2011; Kuo, Tran, Shah, & 
Matorin, 2015). Multiple Sclerosis (MS) is one such chronic progressive disease of the 
Central Nervous System (CNS). It is comprised of inflammation, demyelination, and 
axonal degeneration that can create a wide array of symptoms including physical, 
psychological and cognitive difficulties (Achiron et al., 2013). The author also stated that 
the progression of the MS symptoms, however, is somewhat unpredictable and often 
leads to irreversible functional impairment. Depression is the most common mental health 
problem in primary care settings especially among people with a chronic illness (Beal, 
Stuifbergen, & Brown, 2007; Huang et al., 2010; Lynch-Jordan, Sil, Bromberg, Ting, & 
Kashikar-Zuck, 2015). In addition, depression may reduce the likelihood that individuals 
with chronic illness will comply with treatments or engage in useful self-care strategies 
(O'Connor et al., 2016). As such, depression is a significant concern among primary care 
providers because the presence of depression may negatively impact the effectiveness of 
treatment provided for the chronic illness. On a similar note, depression is the most 
common psychiatric condition in older people with MS (PwMS) (Feinstein, Magalhaes, 
Richard, Audet, & Moore, 2014; Guhne, Stein, & Riedel-Heller, 2016). Various research 
studies, as well as several reviews, have shown that the presence of MS makes an 
individual more vulnerable to depressive symptoms (Feinstein et al., 2014; Mrabet, Ben 
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Ali, Kchaou, & Belal, 2014; Siegert & Abernethy, 2005). Most research studies, however, 
focused on individuals who were recently diagnosed with MS (Hind et al., 2014; Janssens 
et al., 2003; Nourbakhsh, Julian, & Waubant, 2016). This is because the symptom 
severity and the disease course are more unpredictable in nature when MS is recently 
disganosed. Unpredictability often leads to depression. As such, conventionally, it is more 
apporpriate to have recenty diagnosed individuals as reseach population. Additionally, 
MS researchers report that depression negatively affects MS symptoms and exponentially 
increases morbidity and mortality rates in PwMS (Feinstein, 2011; Wallin, Wilken, 
Turner, Williams, & Kane, 2006). However, not many studies have focused on the risk 
factors of depressive symptoms in older PwMS. Older adults in this present study are 
those individuals who are of age 55 years and older.  
An essential aspect of treating and preventing depression in older PwMS is 
identifying the factors that make an individual more vulnerable to developing depression. 
Individuals in primary care settings often report various somatic symptoms of depression 
(e.g., fatigue) that may overlap with symptoms of MS and makes diagnosis of depression 
difficult (Gunzler et al., 2015; Tylee & Gandhi, 2005). Therefore, it is important to 
explore the risk factors of depression because it will assist in the screening process by 
primary care providers for individuals who report those risk factors. According to 
McGuigan and Hutchinson (2006), approximately 25% of PwMS who have depression 
are undiagnosed and consequently not treated. For example, fatigue or cognitive 
difficulties may be due to either MS or depression. However, if medical professionals are 
aware of the risk factors of depression in older PwMS, then, only those individuals with 
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the risk-factors can be more formally assessed for depression. This screening process of 
individuals for risk-factors of depression can save more time for the primary care 
provider and it will also help in providing appropriate treatment more promptly for those 
in need (e.g., fatigue caused by depression may be treated by psychotherapy, while 
fatigue caused by MS may be treated by MS specific medications). Timely treatment of 
depressive symptoms may ultimately help manage exacerbation of MS symptoms and 
promote treatment adherence (Feinstein, 2011). Limited attention is given to studying 
predictors of depression in older adults with MS. In a primary care setting, several lines 
of research showed the adverse effect of depression on the perception of one’s disability 
wherein individuals often amplify their symptoms and perceive the symptoms as more 
devastating than when objectively measured by a health care professional (Becofsky, 
Baruth, & Wilcox, 2013; Nabolsi, Wardam, & Al-Halabi, 2015). However, studies have 
not explored if negative perception about one’s ability or higher perceived disability is a 
risk factor for developing depression.  
This study aims to explore the personal and disease-related factors that may 
predict depression in older PwMS. This research uniquely contributes to the body of 
literature by drawing on a nationally representative sample of Canadian older PwMS. The 
results will potentially lead to better facilitation of advocacy and support for the 
prevention, early diagnosis, and treatment of depression in older PwMS. Overall, we aim 
to promote healthy living and healthy aging with a chronic condition in PwMS by 
understanding the risk factors of depression in this population.   
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Chapter 2  
Literature Review 
2.1 Introduction to MS 
Multiple sclerosis (MS) is a chronic inflammatory disease of the central nervous 
system (CNS). It is an autoimmune disease in which the immune system attacks and 
destroys the protective lining (myelin) that covers the nerves of the CNS. This process is 
called demyelination (National MS Society, 2015). Demyelination of nerve fibres causes 
sensory and/or physical (e.g., poor sight, bladder function and bowel movement), motor 
(e.g., tremor, poor coordination, loss of sensation, pain, and fatigue), mental, and/or 
emotional (e.g., cognitive difficulties, depression anxiety, and pathological weeping and 
laughing) impairments (Haussleiter, Brune, & Juckel, 2009). Some symptoms remit 
during the early stages of the disease, and later, most PwMS undergo chronic progressive 
deterioration of their symptoms. The remitting and relapsing processes are often 
unpredictable and may lead to irreversible functional disabilities (Achiron et al., 2013).  
According to Hooper (2011), there are mainly four different types of MS that 
individuals can be diagnosed with: relapsing-remitting MS (RRMS), secondary-
progressive MS (SPMS), primary-progressive MS (PPMS), and progressive-relapsing MS 
(PRMS). The classifications of these four categories are based on how far the disease has 
progressed over time in each individual. According to the public information catalogue 
published on the National MS Society by Hooper (2011), RRMS is the most common 
type of MS with approximately 85% of PwMS being diagnosed with this type. In this 
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type of MS, the symptoms first appear, and then partially or fully remit before they are 
followed by an acute relapse. The severity of symptoms does not worsen between the 
relapse phases, and MS does not progress. The second type, SPMS, is the second phase of 
RRMS. Half of the people with RRMS eventually transition into SPMS 10 to 20 years 
after their MS diagnosis (Tremlett, Yousefi, Devonshire, Rieckmann, & Zhao, 2009). 
SPMS is characterized by fewer recoveries of symptoms following attacks, and a gradual 
worsening of symptoms between each attack leading to progressive disability. 
Approximately 10% of PwMS are diagnosed with the PPMS (Hooper, 2011). In this type, 
disability progresses gradually and continuously from the onset of MS without any acute 
relapses. The final type of MS, the PRMS, is the rarest form with only 5% of PwMS 
receives this diagnosis. It is characterized by a steady decline in symptoms from the 
onset, with intermittent relapses.  
MS affects approximately 2.5 million people worldwide (Beck, Metz, Svenson, & 
Patten, 2005). In Canada, the rate of MS ranges between 55 and 240 per 100,000 people, 
which places Canada among the countries with the highest rates (Beck, Metz, Svenson, & 
Patten, 2005). Beck et al. (2005) reported that in Canada, Atlantic Provinces have the 
highest rate of MS followed by the Prairies, BC, and Ontario, and Quebec has the lowest 
rate of MS. The age of onset for PwMS is between 20 and 50 years with its peak at 
approximately 30 years (Haussleiter et al., 2009; Ramagopalan & Sadovnick, 2011). 
Various factors are found to make individuals more susceptible to MS. For instance, 
genetics and familial factors, ethnic factors, with Caucasian males showing higher MS 
rates than their African, Mexican, Native American, Puerto Rican Japanese, Chinese, and 
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Filipino counterparts (Ramagopalan & Sadovnick, 2011). Regarding environmental 
factors, Ramagopalan and Sadovnick (2011) argued that, while previous studies showed a 
lower risk of MS among people living close to the equator, a study conducted in 
Catalonia, Spain by Otero and colleagues in 2010, and Argentina, South America by 
Cristiano and colleagues in 2009 did not support the above statement. According to Ebers 
(2008), studies conducted in Canada and Australia, provided substantial evidence for 
several other environmental factors (e.g., latitude, sunlight, availability of vitamin D, and 
photobiology) that influence the unusual geographical distribution of MS. Ramagopalan 
and Sadovnick (2011), added that other factors that place individuals at a higher risk for 
MS, are infection with Epstein-Barr virus (EBV), and smoking. With respect to sex 
differences, it was found that MS was two to three times more common in women than 
men (Pozzilli et al., 2003). Ramagopalan and Sadovnick (2011) shared their observation 
on the ambiguity in understanding the prevalence of MS and noted that there were diverse 
factors that make an individual vulnerable to MS and that no single factor was common 
and present in all PwMS. As such, it is unlikely that one single factor or event is 
responsible for MS, but instead, it develops in genetically susceptible individuals as a 
culmination of individual habits and environmental exposures.   
As the evolution and course of MS are unpredictable, disabilities caused by this 
disease are inconsistent, but the illness is always associated with reduced activity levels 
(Haussleiter et al., 2009). As such, MS poses a significant threat to the physical and 
psychological well-being of individuals, often forcing them to be prepared for several 
unannounced challenges. For example, a recent study conducted in a New Zealand 
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population with MS by Alla et al. (2016) predicted that with progressing time, the 
majority of PwMS would develop extensive and irreversible locomotive disability. The 
authors reported that the progression of MS, its uncertain course, and its irreversible 
symptoms cause numerous problems both on a physical and psychological level (e.g., 
depression). These problems may be a direct result of MS (e.g., biological causes) or due 
to adjustment difficulties related to the disease (e.g., psycho-social causes) (Feinstein, 
1995). Secondary health concerns, both physical (e.g., hypertension, hyperlipidemia, and 
chronic lung disease) and psychological (e.g., depression and anxiety), are very common 
in MS and have a significant adverse impact on the multi-dimensional domains related to 
physical, mental, emotional, and social functioning known as the health-related quality of 
life (HRQoL) (Marrie, Reider, et al., 2015; Marrie, Reingold, et al., 2015; Nourbakhsh et 
al., 2016; Sahakyan, Avagyan, Avetisyan, & Manvelyan, 2013).  In a review on the 
effects of comorbidities on MS, Marrie and Horwitz (2010) reported that psychiatric and 
physical conditions in PwMS produce complex interactions that have both direct and 
indirect negative implications on HRQoL. 
The working definition of older adults by the WHO took into consideration 
various aspects such as social class differences and/or functional abilities related to the 
workforce (Kowal & Dowd, 2001). According to Kowal and Dowd (2001), most 
developed countries in the world have accepted the chronological age of 65 years as a 
definition of an older person which corresponds to the age of retirement. According to 
Gorman’s description of old age (as cited in (Kowal & Dowd, 2001)), although a 
chronological age of 60 or 65 marks the beginning of old age in developed countries, it is 
PREDICTORS OF DEPRESSION IN MS 
8 
 
not the same for developing countries. He states that social constructs such as social roles 
and contributions also define old age. In many instances, social contributions and loss of 
social roles decrease due to the presence of health-related difficulties which may be 
attributed to a chronic illness. It is acknowledged that the working definition of older 
adults with a chronological age of 55 is somewhat arbitrary and introduces difficulties in 
comparing data with other research on older adults that recruited samples with age 65 
years and above. However, in case of this present study, is also believed that 55-year old 
individuals with a chronic illness like MS, are a better representation of the working 
definition in people with chronic diseases who are functionally, physically, cognitively, 
and psychologically more vulnerable than older adults in the general population. Other 
studies on MS also used 55 plus adults as their sample population and called them older 
adults (Finlayson, 2004).  
2.2 Depression and MS 
Depression is a term that encompasses several depressive disorders, including 
major depressive disorder (MDD), and persistent depressive disorder (American 
Psychiatric Association, 2013). Universally, depression is the leading cause of disability 
and a significant contributor to the disease burden among adults in high-income countries 
(O'Connor et al., 2016; Wang et al., 2017). According to the World Health Organization 
(WHO) (2012), 350 million people worldwide suffer from depression. The Diagnostic 
and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) states that depression 
is characterized by a sad mood, loss of interest in individuals’ usual activities, sleep 
disturbances, fatigue, irritability, reduced appetite, negative self-image, decreased 
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concentration and suicidal ideation (American Psychiatric Association, 2013). While a 
diagnosis of clinical depression needs to fulfil specific criteria as provided by the DSM-5, 
depressive symptoms, on the other hand, may be characterized by any symptoms 
mentioned above along with general feelings of sadness.  
Depression negatively impacts an individual’s holistic well-being including their 
personal, academic, occupational, interpersonal, and social activities (Mrabet et al., 
2014). Depression also poses an increased risk for suicide and is a significant determinant 
of low quality of life, accounting for nearly 50% of psychiatric visits and 12% of all 
hospitalizations (Kuo et al., 2015). According to Statistics Canada’s 2012 Canadian 
Community Health Survey (CCHS) on Mental Health report, 5.4% of Canada’s 
population over the age of 15 reported symptoms of mood disorder in the past 12 months. 
A recent community health survey on the perceived need for mental health care in Canada 
highlighted that there are high rates of unmet mental health care needs among people with 
depression (Sunderland & Findlay, 2013). As such, recognizing predictors of depression 
seems to be a crucial aspect of identifying and meeting mental health care needs of 
community dwellers in Canada. It is noteworthy that, while a diagnosis of depression can 
only be made after a thorough assessment by medical professionals with the help of 
structured interview questions and self-report measures, the presence of depressive 
symptoms (i.e., when not meeting full criteria for any depressive disorders as suggested in 
the DSM-5) may pose similar or even greater risk to individuals as they often remain 
undiagnosed.  
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The prevalence of depression or depressive symptoms is higher in primary care 
patients than in the general population (Gunn et al., 2006; Kuo et al., 2015). Depression 
and depressive symptoms is the most common psychiatric disorder, and it is more 
common in PwMS than in the general population with a prevalence rate of approximately 
20 to 60% (Andrade, 2011; Feinstein et al., 2014; Marrie, Reingold, et al., 2015; 
Sabanagic-Hajric, Suljic, & Sulejmanpasic-Arslanagic, 2016; Zorzon et al., 2001). 
Another recent research study by Berrigan et al. (2016), also reported a high prevalence 
of depression in PwMS as they investigated the impact of physical and psychiatric 
comorbidities in HRQoL in PwMS. The study by Berrigan et al. (2016) was conducted on 
949 PwMS from four Canadian MS centres and they found that depression was the most 
frequently reported concern (29%), followed by physical conditions such as hypertension 
(17.8%), and hypercholesterolemia (12.4%), while anxiety was reported by only 11.5% of 
PwMS. Most often, the above percentages merely reflect those individuals who were able 
to identify their symptoms and communicate them to their medical professionals. It will 
not be astonishing if the overall rate is much higher than what research studies estimate. 
The reported lifetime risk of depression in PwMS is about 20% to 50% higher than that 
observed in the general population, as well as, in people with other chronic illness such as 
arthritis, and diabetes (Beal et al., 2007; Katon & Ciechanowski, 2002; Sarisoy, Terzi, 
Gumus, & Pazvantoglu, 2013). A study conducted in a tertiary medical centre in Mexico 
City investigated 44 PwMS and 25 healthy controls to evaluate neuropsychiatric 
symptoms. The researchers found that nearly 95% of PwMS and 16% of the control 
subjects had some neuropsychiatric symptoms, the majority (79%) of which were 
depressive symptoms (Diaz-Olavarrieta, Cummings, Velazquez, & Garcia de la Cadena, 
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1999). However, the mechanisms behind the increased prevalence of depression in PwMS 
are controversial (Maier et al., 2015). A consensus group of experts in MS and depression 
reported that a combination of psychosocial, neurobiological, and disease-related factors 
is likely responsible for the high prevalence of depression in this population (Goldman 
Consensus, 2005).  
Katon (2011) described a bidirectional relationship between depression and 
chronic illness. He demonstrated that the biological changes and negative health 
behaviours associated with depression worsen the chronic disease. Furthermore, he 
showed that the biological, physical and psychological burdens associated with chronic 
conditions could also amplify depressive symptoms. Apart from the high cost related to 
treating depression alone, Katon’s research also suggested that depression worsens 
physical functioning, interferes with self-care, and increases the risk of mortality in this 
population. Over the past few decades, researchers have portrayed the significant negative 
impact of MS on mood (Mrabet et al., 2014). Studies also show the negative effect of 
depression on quality of life (QoL) in PwMS and a suicide rate 7.5 times higher than 
among healthy individuals (Andrade, 2011; Feinstein et al., 2014). While the 
pathogenesis of depression in PwMS is debatable, researchers investigating the social 
aspects of the impact of MS suggested that factors such as response to the disease, 
disability caused by the disease, prognostic uncertainty, lack of social support, 
unemployment, and negative coping strategies play a significant role in the prediction, 
development, and maintenance of depressive symptoms (Dalton & Heinrichs, 2005; 
Wood et al., 2013). In terms of other physical and psychiatric conditions and their impact 
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on mood, Berrigan et al. (2016) found that depression had an adverse effect on HRQoL in 
PwMS. However, the researchers also found that the impact of different physical 
comorbidities on PwMS was mediated by the presence of depression. Scientists have 
shown that depression affects physical disability as well as impacts the perception of 
disability which often magnifies the disease-related symptoms (Becofsky et al., 2013; 
Haussleiter et al., 2009; Smith & Arnett, 2013; Smith & Young, 2000). However, studies 
have not explored if negative perception of individual’s disability is a risk factor for 
developing depression.  
Diagnosing depression in the context of MS may pose various difficulties which 
candidly illustrate the challenges that healthcare professionals may face. For example, 
Dalton and Heinrichs (2005), reported that it is often hard to distinguish depressive 
symptoms that are caused by damaged nerves responsible for mood regulation from those 
caused by mood disorder due to adjustment difficulties because of MS. As such, it 
appears that healthcare professionals need to be able to distinguish a person’s organic 
MS-specific psychopathologies, and reactive psychological symptoms due to MS. 
Feinstein et al. (2014) discussed various significant difficulties in depression diagnosis in 
PwMS in their review of the link between depression and MS. They noted that, according 
to the DSM-5, the persistent low mood in PwMS could be categorized under three 
different mood disorders, namely adjustment disorder, depressive disorder due to a 
medical condition, and major depressive disorder. For example, an individual’s 
depressive symptoms could be caused by  inflammation of nerve fibres which may be 
considered a depressive disorder due to a medical condition, while, an individual’s 
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depressive symptoms due to psycho-social difficulties as a result of MS may be termed an 
adjustment disorder. Tylee and Gandhi (2005) emphasized that, although the diagnosis of 
depression is mostly confirmed by the presence of psychological symptoms, nearly two-
third of patients’ clinical picture is painted by somatic symptoms, such as a lack of 
energy, fatigue, and general aches and pains. Some symptoms such as fatigue, changes in 
sleep patterns and appetite, poor concentration, and memory difficulty may also be 
associated with neurological changes due to MS and can be mistaken as symptoms of 
depression or vice-versa (Feinstein et al., 2014). The authors stated that these symptoms 
may also influence the self-rating measure (e.g., the revised Beck Depression Inventory) 
commonly used for depression by PwMS, which is heavily loaded with somatic 
symptoms. However, in order to avoid over or under reporting of symptoms due to this 
overlap, researchers use the Hospital Anxiety and Depression Scale (HADS) which 
focuses more on the psychological aspect of depression rather than somatic symptoms 
(Feinstein et al., 2014). McGuigan & Hutchinson (2006) reported that approximately one-
quarter of PwMS with depression are undiagnosed and untreated. Long-term undiagnosed 
depression can affect the overall QoL of people, which may, in turn, worsen MS-related 
symptoms (Feinstein, 2011). Very few PwMS receive treatment for major depression 
from their healthcare providers, as is shown in the study by Feinstein (2002). Feinstein 
found that only one-third of PwMS were being treated for major depression. Depression 
is very prevalent in PwMS, and yet very few are treated for it. As such, a significant 
aspect of promoting the assessment and treatment of depression is to further educate both 
healthcare providers and clients about the risk factors of depression and the importance of 
identifying it in a timely manner.  
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Although the aetiology and prevalence of depression in PwMS have received 
significant attention over the years, not many PwMS have participated in studies focusing 
on treatment for depression (Beal et al., 2007; Mrabet et al., 2014). Depression has been 
found to interfere with treatment adherence in general (i.e. individuals without primary or 
mental health problems) and in primary-care populations (DiMatteo, Lepper, & Croghan, 
2000; Stein-Shvachman, Karpas, & Werner, 2013). In terms of older adults in the general 
population, a systematic review and meta-analysis by Cole and Dendukuri (2003) 
searched relevant articles published between 1966 and 2001 on older (i.e., 50 years and 
older) community dwellers. The review showed that according to 20 studies, risk factors 
for depression included disability and poor health status related to medical-illness-
complicated grief, sleep difficulties, loneliness, and a personal history of depression (Cole 
& Dendukuri, 2003). Another review by Stein-Shvachman et al. (2013) emphasized that 
there are mixed results available in the literature with regards to treatment adherence in 
younger versus older depressed people and that the presentation and predictors of 
depression between the two groups also vary. The study by Katon (2011) demonstrated 
various difficulties that depression poses on the medical population in terms of increased 
risk of medical symptoms, functional impairment, the cost associated with the treatment 
of primary disease, and low treatment adherence. Foley, Mohr and their colleagues (as 
cited in (Mohr, Classen, & Barrera, Jr., 2004) p. 534) identified numerous studies that 
highlighted the treatability of depression through psychotherapy and antidepressant 
medication in PwMS (Foley et al. 1987; Mohr & Goodkin, 1999; Mohr et al. 2000; Mohr, 
Goodkin, Islar, Hauser, & Genain, 2001). However, because a complete cure for MS is 
not yet known, scientists are focusing on disease-modifying therapies of MS by delaying 
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or preventing long-term disability (Goodin, Frohman, Halper, Likosky, & Lublin, 2002). 
As such, this study aims to provide information that will corroborate previous findings on 
prevalence and predictors of depression, thereby lowering the risk of depression in 
PwMS. Results of this research may also help in emphasizing the importance of giving 
clinical attention to the treatment of depression. This is because a complete remission of 
depression may assist in better managing MS-related symptoms (Marrie et al., 2009; 
Mohr et al., 2001; Siegert & Abernethy, 2005). 
2.2a Predictors of Depression in Individuals with MS  
 Considering depression is very common in PwMS, an essential goal of clinicians 
and healthcare professionals, therefore, involves preventing and managing depression in 
this population. This might be accomplished by understanding social, behavioural, 
individual, and disease-related predictors of depression in PwMS (Beal et al., 2007; Hind 
et al., 2014; Marrie et al., 2009). The impact of depression varies among the primary 
health care population and the general population (Feinstein et al., 2014; Scott B Patten et 
al., 2005; Sabanagic-Hajric et al., 2016). The aetiology and symptomatologies of 
depression also vary across different age groups such that there is a more diverse 
attribution of depression in the older adults than in younger ones (Gottfries, 1998). For 
example, according to the study conducted by Gottfries (1998), biochemical changes in 
the brain of an older person and changes in neurodegenerative disorders are one of the 
many factors that add to the diversity of the cause of depression in older population. A 
systematic review that looked at 43 papers on PwMS whose average age ranged from 42 
to 48 years found adjustment difficulties to be a probable cause of depression in these 
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individuals (Hind et al., 2014). Another review of depression and MS that collected data 
from MS clinics, community samples, and administrative health databases in Canada, 
showed that individuals between ages 18 to 45 have a one in four chance of developing 
depression over the course of one year (Feinstein et al., 2014). When individuals are busy 
shaping their personal and professional goals, being confronted with a lifelong chronic 
disease disrupts various aspects (e.g., professional, personal, social, financial) of their life. 
This often leads to adverse social and psychological consequences. As such, many 
researchers recruit adults with a wide age range (e.g., 18 to 85 years) to be able to include 
those in their career-building stage as well as those who are elderly (Feinstein et al., 2014; 
Mrabet et al., 2014). One of the probable reasons behind choosing a younger population 
may be to explain the impact of adjustment difficulties and to focus on depression as a 
result of the various challenges faced in accommodating the demands of MS. MS research 
has shown several personal factors as predictors of depression in PwMS such as age, 
gender, employment status, and social support, as well as disease-related factors such as 
the type and severity of MS, number of years living with MS, presence of comorbidities, 
and one’s functional status (Beal et al., 2007; Gay, Vrignaud, Garitte, & Meunier, 2010; 
Hind et al., 2014; Marrie et al., 2009; Miller & Dishon, 2006; Seyed Saadat, 
Hosseininezhad, Bakhshayesh, Seyed Saadat, & Nabizadeh, 2014). Most of these 
research studies have used a relatively young sample who were newly diagnosed with MS 
or have used PwMS from a wide age range (e.g., 18 years and above). However, for over 
two decades, few studies focused on predictors of depression among older PwMS in their 
pre-retirement age (e.g., 55 years and over) who have been living with MS for many years 
(He et al., 2013; Nourbakhsh et al., 2016; Ploughman, Harris, et al., 2015). There could 
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be much to be learned from this group. For example, PwMS who have been living with 
their disease for over 20 years may not have depressive symptoms due to adjustment 
difficulties as these individuals may have learned ways to cope with the challenges and 
may be aware of the disease patterns. As such, depression due to the unpredictable course 
of MS may not be a concern for these individuals. Moreover, as noted by Tremlett et al. 
(2009), the unpredictability of MS symptoms, its course, and its severity is mostly seen in 
the RRMS type which is often the initial type of diagnosis in PwMS. But, in most cases 
10 to 20 years after their diagnosis, individuals transition to the SPMS type in which the 
symptoms of MS gradually worsen, leading to progressive disability without remission. 
Therefore, those PwMS who have been living with this disease for over 20 years may be 
depressed due to progressive disability rather than the unpredictable relapse or remission.  
To achieve a healthy-aging process in older PwMS, identification of modifiable 
risk factors for depression is imperative. This research will attempt to identify those 
factors that make older adults with MS more vulnerable to depression. The results of this 
study may be able to inform health care professionals of the preventative measures that 
can be considered to manage depression, and that may also help in lowering the overall 
burden due to MS. From the existing literature, this study has identified various factors 
(e.g., gender, age, financial condition, social support, and perceived disability, number of 
years living with MS, physical comorbidity, early retirement due to MS, and physical 
disability) that may be responsible for making an older adult with MS more vulnerable to 
depression.  
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2.2a.i Age 
 According to Statistics Canada (2015), one in six Canadians (16.1%) was at least 
65 years old in 2015, and this figure outnumbered children between zero to 14 years for 
the first time in Canadian history. They also noted that, by the year 2024, the 65-years-
old-and-above population would account for nearly 20.1% of Canada’s population. 
According to Warnick (as cited in (Singh & Misra, 2009)), aging is portrayed as the final 
stage in one’s lifespan and concludes one’s life cycle. However, the age group that the 
present study focuses on is 55 years and older which is the pre-retirement age. The 
retirement age in Canada is 65 years (Canada Pension Plan, 2016). As noted earlier in this 
paper, according to Kowal and Dowd (2001), although the chronological age of 65 years 
is accepted as a working definition of an older person because it corresponds to the age of 
retirement, in many cases, social contribution, and functional ability define old age. As 
this study uses a group of people who have been living with a physically disabling 
chronic disease, for over 20 years, the working definition of older adults is set as 
individuals with a chronological age of 55. Another study on PwMS also used individuals 
between ages 55 and 81 and called their sample “older adults” (Finlayson, 2004). 
Age is an important factor in determining the onset of depression. According to a 
report on mental illness in Canada by the Public Health Agency of Canada (2002), in 
most cases the onset of depression occurs during adolescence. Loss of productivity for the 
patient, as well as medical and hospitalization costs incurred due to depression, are 
thought to be two main reasons why the Canadian economy is affected by depression 
(Public Health Agency of Canada, 2002). According to the Centres for Disease Control 
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and Prevention, the 2012 Morbidity and Mortality Weekly Report, the highest prevalence 
rate of depression in general population was approximately 7% for males and 12% for 
females. The age group of these individuals were between 40 and 59 compared to those 
above 60 years, for whom a prevalence rate was 5% for males and 7% for females. The 
younger counterparts (i.e., those between age 18 and 39 years) reported a prevalence rate 
of 11% for females and 5% for males. The survey used the Patient Health Questionnaire 
to assess the current rate of depression of the participants and defined depression by the 
presence of symptoms for two weeks with a cut-off score of ≥10 out of a total score of 27 
("QuickStats", 2012). 
Research has shown depression to be one of the most frequently occurring mental 
disorders in older adults and is associated with increased disability and mortality risks 
(Rodda, Walker, & Carter, 2011). A review of the literature between 1990 and 2001 by 
Rosenvinge and Rosenvinge (2003) suggested that nearly 10-19% of older people (i.e., 
above age 65 years) from the general population have symptoms of depression. In the 
year 1992, Williamson and Schulz’s research study portrayed clinical depression to be 
relatively uncommon among older adults with only 4% of 60 years or older being 
clinically depressed, but they also noted that the presence of depressive symptoms, on the 
other hand, was much more common (as cited in (Hoffman, Hays, Wallace, Shapiro, & 
Ettner, 2017)). A study on a community-dwelling cohort of older adults over age 65 years 
reported a similar relationship between age and depression, with older people being more 
affected by mood disorders than their younger counterparts (Blazer, Burchett, & George, 
1991). In terms of depression and advancing age, most research target seniors (i.e., 65 
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years or older) and there are not many studies that focus on depression in older adults in 
their pre-retirement age (Blazer et al., 1991; Guhne et al., 2016; Kneebone, Dunmore, & 
Evans, 2003). The authors reported that older adults in pre-retirement age have unique 
challenges and needs and are often faced with significant difficulties in social, physical 
and psychological aspects which may be different from the elderly people. Having a 
chronic condition such as arthritis, heart disease, diabetes and/or MS poses more threat to 
the mental wellness in this population.  
Many studies in the MS literature have used similar age ranges when describing 
studies conducted on older adults. For example, an explanatory research study on health 
issues and service needs with PwMS used a sample of older adults with age ranging 
between 55 to 82 years (Finlayson, 2004). It is observed that while some studies reported 
a higher prevalence of depression among older PwMS (Seyed Saadat et al., 2014), others 
have not shown such results in MS population (Patten, Metz, & Reimer, 2000). Some 
have argued that older adults (age 65 years and older) seemed to be less vulnerable to 
depression which was mainly due to the fact that older adults were less emotionally 
responsive (Kneebone et al., 2003). Mixed results in the literature regarding age as a 
potential risk factor for depression in PwMS, seem to indicate that different aspects 
account for the prevalence, development, and vulnerability to depression in different age 
groups. For example, younger and recently diagnosed PwMS show signs of depression 
due to their difficulties in adjustment with an unpredictable disease, poor health status 
when compared to their previous condition and anticipating future disability (Janssens et 
al., 2003). However, this may not be the case for older adults (age 55 to 88) who have 
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learned to live and cope with MS for over two decades (Ploughman et al., 2012). 
Therefore, if older adults with MS have already addressed their depression related to MS 
diagnosis by learning to adjust to the unpredictable disease and anticipating future 
disability, then is age still a predicting factor for depression in this population? 
Experience of growing old varies considerably among older adults. Therefore, for a more 
accurate portrayal of significant life changes, some gerontologists have emphasized 
defining sub-groups instead of lumping all older people in one group. For example, one 
study used sub-grouping as young-old (65 to 74), middle-old (75–84), and oldest-old 
(85+) (Zizza, Ellison, & Wernette, 2009). Although older adults in this study are those 
individuals who are 55 years and over, it is acknowledged that age-related difficulties will 
be different within this age group (i.e., 55 years to 88 years). 
2.2a.ii Gender 
 According to Loue (2008), in recent times, scholars have defined gender as a 
function of culture, while sex is a function of biology, unlike the traditional views where 
biological sex, gender role, and social identity were linked and used interchangeably. In 
Loue’s book on Encyclopedia of Aging and Public Health, sex was referred with terms 
such as “male” and “female,” while terms like “masculinity” and “femininity” were used 
to refer to gender. In the MS literature some researchers prefer to use the term “sex” to 
denote the two main groups (e.g., men and women) based on the reproductive function 
that categorized their target population, while others used the term “gender” (Alla et al., 
2016; Beal et al., 2007; Chwastiak et al., 2002; Magyari, Koch-Henriksen, Pfleger, & 
Sorensen, 2014). As such, for convenience and to avoid changing previous authors’ terms 
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when referring to the literature, the term “gender” and “sex” will be interchangeably used 
in this study. However, it must be also acknowledged that confounding factors will be 
associated by interchanging the words.  
Epidemiological findings over decades have produced mixed results about the 
relationship between the prevalence of depression and gender. A survey by the Centers 
for Disease Control and Prevention reported a higher prevalence rate of depression in 
women across all ages (>12 to >60 years) ("QuickStats", 2012). Piccinelli and Wilkinson 
(2000) were also of the same opinion that depression is more prevalent in women than 
men. Females carry twice the risk of depression compared to males which also 
corresponded to their relapse rate (Kessler, 2006; Kuehner, 2003). Studies have shown 
that women tend to use more social support and friends than their male counterparts 
which lead to more communication about their mood-related difficulties to their friends 
and families, resulting in receiving treatment for depression (Dalgard et al., 2006). As 
such, women are seen to be more articulate when it comes to expressing their difficulties, 
also making it easy for healthcare professionals to provide a fast and effective treatment. 
Other reasons for gender disparity may be hormonal effects, genetic vulnerabilities, and 
the reproduction process (Dorn & Chrousos, 1997; Kooiman, Jansen, & Peeters, 2006). 
Leach, Christensen, Mackinnon, Windsor, and Butterworth (2008) alluded to several 
psychosocial, and functional factors that were responsible for the gender difference 
including physical health, physical activity, and perceived interpersonal and employment 
problems. Individual factors that make women more vulnerable to depressive symptoms 
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may also include different cognitive styles of processing and managing depression such 
as rumination (Nolen-Hoeksema, 2000).  
The above view was not supported by other studies that showed higher rates of 
depression in men compared to women (Emslie, Ridge, Ziebland, & Hunt, 2007; 
Nortvedt, Riise, & Sanne, 2006). In the recent past, research focusing on men’s mental 
health has received much attention due to the increased suicide rates in men (Hunt, 
Sweeting, Keoghan, & Platt, 2006). Men have a higher rate (i.e., three to seven times) of 
death by suicide across all ages compared to women (Nock et al., 2008). The importance 
of socially constructed gender roles has been an essential determinant in the experiencing 
and reporting of depressive symptoms (Vafaei, Ahmed, Freire Ado, Zunzunegui, & 
Guerra, 2016). In many societies (i.e., eastern and western), masculinity is the dominant 
role which reflects strength, and emotional control, which is opposite to what is expected 
of a feminine role comprising of vulnerability and emotional expression (McQueen & 
Henwood, 2002). Although gender roles are different from biological sex, it is still an 
important aspect that impacts the mood of male individuals. While it is more socially 
acceptable for women to express emotional distress, men may choose to be less articulate 
to prove their masculinity and as such their depression may go undiagnosed (Brownhill, 
Wilhelm, Barclay, & Schmied, 2005). This phenomenon of depression and gender role 
were also well documented by Vafaei et al. (2016) who reported that older adults with 
androgynous life roles reported lower rates of depression. In other words, men or women 
who are not strict followers of gender roles according to social expectations may be less 
affected by depression because of lack of gender-related tasks as defined by the society. 
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According to Loue (2008) gender role refers to what individuals do or how they 
communicate with others and to themselves that would suggest they are males, females, 
transgender, or androgynous.  
Studies showed that in primary care settings, female patients reported more 
psychological impairment than male patients (Di Marco et al., 2006; Magyari et al., 
2014). On the other hand, functional and occupational impairments were reported to be 
significant challenges for males (Alla et al., 2016). Research findings in PwMS, show 
mixed results whereby some studies supported the association between female gender and 
depression, and other studies reported that gender was not a significant predictor of 
depression (Alsaadi et al., 2015; Beal et al., 2007; Patten et al., 2000; Zorzon et al., 2001). 
Not many studies have particularly focused on gender or sex being a vulnerability factor 
for depression in older PwMS. Therefore, results from this present study will be an 
important contribution as it aims to examine if sex is a risk factor for depression in older 
PwMS, and if so who is more vulnerable?  
2.2a.iii Social Support 
 Various social, economic, geographical, relational, and cultural facets make up 
social support (Faramarzi et al., 2015). It can be comprised of an individual’s significant 
other, friends, families, colleagues, and neighbours. From a healthcare perspective, Cobb 
(1976) defined social support as follows: 
Social support is conceived to be information belonging to one or more of the 
following three classes: 1. Information leading a subject to believe that he is cared 
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for and loved. 2. Information leading the subject to believe that he is esteemed and 
valued. 3. Information leading the subject to believe that he belongs to a network 
of communication and mutual obligation (p. 300). 
Broadhead et al. (1983), (as cited in Grav, Hellzèn, Romild, and Stordal (2012), p. 
112) noted that although social support and depression have been extensively researched 
since the mid-70s, not much attention has been given to the older adults (i.e., above 65 
years). Depression and social support literature on older adults (e.g., 65 years and above) 
demonstrated that social deficits, and adverse life events are risk factors for depression in 
general population as well as in primary health care population (Bambara, Turner, 
Williams, & Haselkorn, 2011; Grav et al., 2012; Mohr et al., 2004; Prince, Harwood, 
Blizard, Thomas, & Mann, 1997; Wu et al., 2013). According to Grav et al. (2012), a 
cross-sectional survey on 40,659 individuals from ages 20 to 89 years, showed that 
depression was most prevalent in older men (age 75 to 89 years) who lack tangible social 
support. Grav and colleague used the HADS to measure depression with a cut-off score of 
also >8, similar to the instrument and the cut-off score used in this present study. 
Sonnenberg et al. (2013) portrayed gender-based differences between depression and 
social support noting that older men with low social support were more vulnerable to 
depression. Recent research has shown the increased need for social support among older 
adults for physical and emotional assistance, emphasizing that social interaction may 
strongly influence HRQoL (Benmarhnia & Zunzunegui, 2014; Khalili, Sam, Shariferad, 
Hassanzadeh, & Kazemi, 2012).  
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The need for social support and its positive impact on overall QoL have been well 
studied in individuals with various chronic diseases (e.g., coronary heart disease, 
fibromyalgia, diabetes, MS, and cancer) in primary care settings across the world 
(Hughes et al., 2014; Lett et al., 2005; Lynch-Jordan et al., 2015; Wu et al., 2013). Coyne 
and colleagues (1987 and 1991) (as cited in Mohr et al. (2004) p. 533) demonstrated that 
depressed PwMS in primary care settings exhibit poor interpersonal behaviours that are 
unappreciated by others which further lead to feelings of rejection and isolation. As such, 
the authors hypothesized that treating mood disorders will in turn increase social support 
which may have a positive impact on MS. Various studies on MS have provided similar 
conclusions, demonstrating the positive impact of social support on disease management, 
lowering emotional distress, and increasing QoL (Aghaei, Karbandi, Gorji, Golkhatmi, & 
Alizadeh, 2016; Costa, Sa, & Calheiros, 2012; Mohr et al., 2004). In older adults (age 55 
to 85 years) with MS, the chronic condition decreases their ability to participate and 
engage in activities to a significant extent (Beekman et al., 2002). A small chore that 
seemed manageable before may now look like a big task, inhibiting many PwMS from 
participating in such activities. This may also include attending community organizations, 
places of worship, and/or attending appointments with health care professionals which 
may negatively affect one’s enthusiasm to live a fulfilled life with a chronic illness. A 
Canadian study by Hystad and Carpiano (2012) noted a strong association between 
community-belonging and health-behaviour suggesting that social belongingness is an 
essential factor that is considered when formulating health prevention strategies. 
Therefore, form the above studies it appears that lack of social support is one of the most 
significant risk factors for depression. As such, adding social support as a potential 
PREDICTORS OF DEPRESSION IN MS 
27 
 
predicting factor for depression in older PwMS is an essential aspect of this research 
study.  
2.2a.iv. Financial Condition 
 According to the American Psychological Association (APA), socioeconomic 
status is often measured as a combination of income, educational level, and occupation 
and is viewed as the social class of an individual. Financial condition, on the other hand, 
is the availability of monetary resources regardless of an individual’s social standing. 
Financial condition may not be the same as socio-economic status. According to 
Butterworth, Rodgers, and Windsor (2009), financial challenges usually determine 
individuals’ difficulties with providing basic necessities for themselves, their family or 
other dependents. A study conducted in New Zealand on college students reported that 
young students who were faced with more financial difficulties were psychologically 
more distressed (Chongpison et al., 2015). On the other hand, an older study by 
Mirowsky and Ross (1999) reported that older adults are less prone to financial distress as 
they are thought to better cope with hardships through life experiences. Research in 
general population showed that both low socio-economic status and poor financial 
condition contribute to stress and depression (Butterworth et al., 2009; Lorant et al., 2007; 
Vinokur, Price, & Caplan, 1996; Wang, Schmitz, & Dewa, 2010).  
Having a chronic disease is associated with significant financial burden and 
deprivation (Jeon, Essue, Jan, Wells, & Whitworth, 2009). For example, researchers 
highlighted that for people with a chronic disease, factors such as regular healthcare 
services, frequent absenteeism from work, unemployment, and early retirement might 
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worsen existing difficulties that are posed by the disease. Jeon et al. (2009) reported that 
affordability of medical treatments promotes self-management and risk reduction 
behaviours which are important aspects to consider when dealing with chronic diseases. 
According to Butterworth, Olesen, and Leach (2012), an individual with a poor financial 
condition is more vulnerable to depression than those who were previously diagnosed 
with depression. Therefore, an individual without any prior depressive symptoms may be 
at risk of developing depression due to financial hardships because of expenses incurred 
from the treatment of a chronic disease, and/or job loss due to the chronic disease. 
Constant financial hardship due to the medical expenses related to a chronic illness may 
prevent individuals from seeking further medical help in fear of worsening their financial 
condition. Such a vicious cycle of rejecting medical assistance due to financial struggle 
can, in fact, exacerbate the medical condition, eventually incurring more expense.  
 Lange and Byrd (1998) examined the impact of perception of financial distress on 
feelings of psychological well-being. They reported that daily financial stress was 
negatively associated with the perceptions of an individual’s capability to manage and 
control their financial condition which ultimately was directly linked with an individual’s 
levels of psychological well-being (Lange & Byrd, 1998). Another research study 
conducted on 576 long-term renal cancer survivors in primary care settings demonstrated 
that depression was associated with a greater perception of financial burden (Chongpison 
et al., 2015). As such, from the studies by Chongpison et al. (2015), and Lange and Byrd 
(1998), it appears that the perception of “not having enough money” is also associated 
with psychological distress.  
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Studies on PwMS have not specifically investigated the impact of perceived 
financial status on depression. Instead, studies have focused on the effects of 
socioeconomic status on depression suggesting that lower socioeconomic status was 
associated with an increased risk of having depression, undiagnosed depression, and 
untreated depression (Marrie et al., 2009). Research investigating income level in PwMS 
found lower levels of income in 916 households with MS in a cross-sectional study 
conducted in the UK (Green, Todd, & Pevalin, 2007). Another cross-sectional study 
conducted by Kobelt, Berg, Lindgren, Fredrikson, and Jonsson (2006) in nine European 
countries found that 60% to 75% of PwMS (N = 13,186) with an average age ranging 
from 45.1 to 53.4 years who have been living with MS for over 18 years, were without a 
job. They also reported that expenses in the household increased with worsening of MS 
symptoms. In PwMS, Orlewska et al. (2005) reported that an individual’s productivity 
loss further adds to the expense that has already been incurred with MS which increases 
the overall economic burden. Thus, it appears that although there is apparently a 
relationship between financial conditions and psychological distress, several factors seem 
to play a role in determining if a poor financial condition is a risk factor for depression in 
older PwMS. Therefore, financial condition is believed to be an important addition to the 
list possible risk factors that may make older PwMS more vulnerable to depression.  
2.2a.v Number of Years Living with MS diagnosis 
Number of years that an individual is living with the formal diagnosis of MS by 
his/her neurologist is defined by the “number of years living with MS” in this study. The 
concept of healthy aging with MS is a relatively new one because the peak prevalence of 
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MS has shifted over the past 20 years, from about 40 years of age to 50 years of age 
(Marrie, Yu, Blanchard, Leung, & Elliott, 2010). This is partly because of early diagnosis 
of MS, better treatment availability, and improved longevity of PwMS (Marrie et al., 
2010). This means that older PwMS can continue to live a meaningful and satisfying life 
even with a chronic disease like MS. However, many researchers have demonstrated that 
greater length of MS or longer time since MS diagnosis is connected to several disease-
related impairments (e.g., fatigue, disability) and psychosocial deficiencies (e.g., 
cognitive difficulties and mood disorders) which may impact their QoL (Achiron et al., 
2013; Alla et al., 2016; Sahakyan et al., 2013). Fatigue, a common symptom of both MS 
and depression has been widely researched as a symptom that worsens over time, and 
studies show a positive connection between fatigue and depression (Fernandez-Munoz et 
al., 2015; Kargarfard, Eetemadifar, Mehrabi, Maghzi, & Hayatbakhsh, 2012; Sabanagic-
Hajric, Suljic, & Kucukalic, 2015). Research has also shown that this positive relationship 
between fatigue and depression in PwMS can be further mediated by advancing age and 
physical disability (Azimian, Shahvarughi-Farahani, Rahgozar, Etemadifar, & Nasr, 
2014; Garg, Bush, & Gappmaier, 2016). In a study with 1,500 PwMS, Achiron et al. 
(2013) showed that cognitive decline is associated with the duration of MS. Cognitive 
difficulties, like memory, attention, and concentration, are also some of the known 
symptoms of depression (Richard et al., 2013). According to Moore et al. (2012), 
variation in depression levels was associated with MS relapse and then at 2 months and 6 
months thereafter. A 6-month longitudinal study of 132 people with relapsing-remitting 
type MS, who were administered the HADS at the time of relapse and at the 2-month and 
6-month period, revealed that almost 50% of PwMS scored above the threshold (i.e., 
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HADS score ≥8) indicating the presence of depression during the assessment. The results 
also demonstrated that even though rates of physical disability as measured by the 
Expanded Disability Status Scale (EDSS) improved suggesting remission from MS, 
levels of depression remained high at 6 months indicating that a portion of PwMS did not 
recover from depression. It appears from the above studies that length of MS has some 
direct or indirect association with depression.  
Other authors claim that disability, and cognitive and emotional difficulties faced 
by PwMS are independent of the duration of MS (Moller, Wiedemann, Rohde, 
Backmund, & Sonntag, 1994; Ploughman et al., 2012). A recent study conducted with 39 
PwMS and 39 healthy controls reported that adaptive coping skills alleviate mood swings 
in people with clinically isolated syndrome (i.e., another form of MS) and RRMS 
(Bianchi et al., 2014). The researchers also noted that older adults who have been living 
with MS for a long time may have learned adaptive coping strategies and have more 
experience with disease management which may act as a protective factor against 
developing depression due to adjustment difficulties. Similar opinion was also expressed 
by Ploughman et al. (2014). Other studies that did not find a correlation between years 
living with MS and depression corroborated the above finding (Arnett et al., 1999; 
Feinstein & Feinstein, 2001; Zorzon et al., 2001). An older study by Rao, Leo, Bernardin, 
and Unverzagt (1991), showed that there was no significant relationship between 
cognitive deficiency and MS duration, depression, MS course, or medication usage.  
The mixed findings in this area support the need to re-consider length of MS or 
number of years living with MS as a potential predictor of depression in older PwMS.  
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2.2a.vi Disability 
According to the definition of disability by the World Health Organization 
(WHO), disability is more than just an individual’s physical or mental health problems; it 
is an intricate interaction between an individual’s physical body and his/her societal 
aspects (World Health Organization (WHO), 2002). Several research studies 
demonstrated the impact of physical disability on depression and vice versa in the general 
population as well as in people in primary care settings (Garg et al., 2016; Oremel, 
Vonkorll, & Brink, 1996; Smith & Arnett, 2013). Studies have also found a close 
association between depression and perceived disability indicating that mood disorders 
often magnify somatic symptoms (e.g., pain and fatigue) giving individuals an impression 
that they are more disabled than when assessed by their physician (Menendez et al., 2015; 
Walsh & Radcliffe, 2002). However, the risk factors of depression in terms of physical 
disability and perceived disability are not yet demonstrated. Moreover, studies have not 
examined which aspect of disability (physical or perceived) is more threatening to 
developing depression in older PwMS.   
2.3a.vi (a) Physical Disability  
Disability is an overarching term that suggests impairment (i.e., difficulty in 
physical function or structure), activity limitation (i.e., obstacles encountered by a person 
engaging in tasks), and participation restriction (i.e., difficulties faced by individuals 
when involving in activities of daily living (ADLs)) (WHO, 2017). According to the 
explanation provided on the official website of the Government of Newfoundland and 
Labrador for Education and Early Childhood Development, individuals with a physical 
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disability are those who have an acquired or congenital physical and/or motor impairment 
(Government of Newfoundland and Labrador, 2017). Physical characteristics of disability 
may include, paralysis, altered muscle tone, an unsteady gait, loss of, or inability to use, 
one or more limbs, difficulty with gross-motor skills, and difficulty with fine-motor skills. 
Several research studies provided longitudinal evidence portraying a bidirectional 
relationship between physical disability and depression (Beekman et al., 2002; Oremel et 
al., 1996; Penninx, Leveille, Ferrucci, Van Eijk, & Guralnik, 1999; Von Korff, Ormel, 
Katon, & Lin, 1992). Researchers have found an association between physical disability 
and depression in other medical conditions, such as fibromyalgia, cancer, and arthritis 
(Geisser et al., 2008; Hackett & Anderson, 2005; Roh et al., 2012; Smeets, 2009). In 
terms of older adults, Geerlings, Beekman, Deeg, Twisk, and Van Tilburg (2001) 
conducted an eight-wave prospective community-based study that investigated the 
longitudinal effect of depression on functional limitations and disability on people with 
chronic physical diseases. Geerlings’ study also had a comparable age group (i.e., 55-85 
years) to the present study. The sample of Geerlings’ study consisted of 325 non-
depressed and 327 depressed people. The researchers found a significant longitudinal 
association between depression and functional limitations due to physical disability.   
Following a review of several research studies it was noted that in PwMS, 
physical disability and fatigue were thought to be the result of pathophysiological 
mechanisms such as inflammation, demyelination, axonal loss, and neuroendocrine 
dysregulation (Bol, Duits, Hupperts, Vlaeyen, and Verhey, 2009; Kos, Kerckhofs, Nagels, 
D'Hooghe M, & Ilsbroukx, 2008). According to Haussleiter et al. (2009), in PwMS, the 
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demyelination of nerve fibres causes physical and psychological impairments that are 
generally irreversible in nature. While some symptoms remit during the early stages of 
MS, the symptoms may later relapse with greater severity and this process is often 
unpredictable and results in functional disabilities (Achiron et al., 2013). Research 
provided mixed results when demonstrating the association between depression and 
disability in PwMS. While some found a positive relationship, reporting greater physical 
disability resulting in depression (Feinstein & Feinstein, 2001; Smith & Arnett, 2013; 
Zorzon et al., 2001), others could not support the same from their research study (Arnett 
et al., 1999; Berg et al., 2000). Lynch, Kroencke, and Denney (2001) studied the 
relationship between disability and depression in 188 PwMS and found that disability was 
an independent predictor of depression. When other psychological factors such as 
uncertainty, hope, and emotion-centred coping were added to disability, together, the 
variables accounted for approximately 40% of the variance in individual’s self-reported 
symptoms of depression. Another study, conducted in the UK, with 4516 PwMS found 
that the percentage of people experiencing depression increased with a physical disability 
such that 17.1% of people with low, and 71.7% with a high disability experienced at least 
mild depression (Jones et al., 2014). In a study, Sabanagic-Hajric et al. (2016) examined 
the relationship between disability and depressive symptoms in 120 PwMS in an acute 
relapse phase and found a moderate correlation between disability and somatic symptoms 
of depression in older adults compared to younger ones. According to Alla et al. (2016), 
the age of an individual, age at onset of MS, and years living with MS are independently 
associated with physical disability noting that with the progression of the above variables, 
disability of the individuals worsens. Gilchrist and Creed (1994) reported that in PwMS, 
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social stress is commonly associated with depression which they think may apparently be 
linked with individual’s physical disability including several other factors such as 
unemployment, financial, and interpersonal problems.  
A recent study that explored the relationship between physical disability, physical 
activity and depression in 27 PwMS found that higher levels of disability were 
significantly associated with more symptoms of depression (Sadeghi Bahmani et al., 
2017). The researchers also reported that physical activity levels did not mediate the 
effect of disability on depressive symptoms. While some studies show disability to be 
independently associated with depression, other studies demonstrated that there was no 
relationship between physical disability and depression. Therefore, it seems pertinent to 
explore if physical disability is a potential risk factor for depression in older PwMS.   
2.2a.vi (b) Perceived Disability  
Perceived disability can be described as one’s perception or views about his/or her 
level of disability. Can depression impact this perception of disability? Arnstein, Caudill, 
Mandle, Norris, and Beasley (1999) explained the complex phenomenon of self-efficacy 
being a determining factor in the development of disability and depression in individuals 
with chronic pain. According to Bandura (as cited in (Marcus, Selby, Niaura, & Rossi, 
1992) p. 61), self-efficacy means the confidence in one’s ability to carry out a certain 
behaviour, and it is associated with one’s actual execution of the behaviour. Therefore, an 
individual’s perception of his/her disability will also determine if he/she can physically 
perform a certain task regardless of their level of physical disability. In a study conducted 
on patients in a shoulder clinic, Menendez et al. (2015) stated that catastrophic thinking 
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and low self-efficacy were associated with greater shoulder pain and disability. They 
concluded that psychological factors seemed to affect an individual’s perception of their 
pain more so than their physical pain. Similar findings were reported in people with 
arthritis, wherein the perception of disability was more strongly associated with 
depressive symptoms than actual physical limitations (Becofsky et al., 2013). As such, 
researchers suggested that psychotherapy for depression should also focus on enhancing 
patients’ self-efficacy in order to deal with their perceived disability (Hainagiu, 2012). 
Various studies conducted in people with chronic illness demonstrated the difficulty in 
diagnosing depression especially when the somatic symptoms of depression (e.g., low 
energy, pain, and fatigue) emulate the symptoms of the chronic disease (e.g., arthritis, 
fibromyalgia, or MS) (Beal et al., 2007; Wolfe & Michaud, 2009). Nabolsi et al. (2015) 
found an association between self-perceived fatigue and activity limitation. The authors 
reported that older adults seem to restrict their participation based on the perception of 
their fatigue compared to their level of fatigue as assessed by physicians. From the above 
research studies, it appears that depression impacts people’s perception of their disability 
often magnifying the symptoms than when functionally measured by a physician. 
However, no one has yet explored if the perceived disability is a risk factor for depression 
in older PwMS.  
In PwMS, only one study focused on the role of depression on patients’ (mean age 
of participants was 46 years) perception of their disability (Smith & Young, 2000). The 
researchers found that according to Beck Depression Inventory and HADS cut-off scores, 
depressed patients were three times more likely than non-depressed patients to perceive 
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their disability as being greater than the physicians’ perception of the patient’s disability. 
However, there are no studies that demonstrate similar findings among older adults with 
MS. As such, exploring perceived disability as a potential predictor of depression was 
thought to be a relevant aspect of this research study.  
2.2a.vii Physical Comorbidities 
According to Valderas, Starfield, Sibbald, Salisbury, and Roland (2009), 
comorbidity is described as the presence of more than one distinct condition in an 
individual. It is defined by the nature of the health condition, the relative importance of 
the co-occurring conditions, the chronology of the presentations of the conditions, and the 
complexities of the conditions with respect to morbidity risks (Valderas et al., 2009). To 
achieve overall progress in health, health care professionals may need to address, manage 
and/or treat multiple coexisting diseases, along with the primary disease (Valderas et al., 
2009). Depression is a very common comorbid condition in primary health care settings 
(Beal et al., 2007). Various chronic diseases are associated with depression which is a 
major source of concern to individuals, families, and medical professionals (Becofsky et 
al., 2013; Chongpison et al., 2015; Lynch-Jordan et al., 2015; Wolfe & Michaud, 2009). 
When an individual is diagnosed with more than one chronic disease, it sometimes 
becomes difficult to identify which disease was responsible for the development of 
depression.  
PwMS can be diagnosed with any number of comorbid diseases. PwMS who may 
not have depression may be suddenly depressed if they develop a comorbid disease 
during their course of MS, such as arthritis, heart disease, cancer or fibromyalgia. 
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Research suggests that depression caused because of a newly diagnosed comorbid disease 
may worsen symptoms of MS (Marrie et al., 2009). On a similar note, studies have shown 
that the interaction of a secondary disease and depression pose challenges in the 
diagnostic process and the management of all the diseases and such challenges can 
significantly delay detection of depression, worsen MS-related symptoms, and decrease 
an individual’s QoL (Allison, 2007; Marrie et al., 2009). The presence of depression 
and/or other psychopathologies as comorbid conditions have been extensively studied 
throughout the literature (Anderson, Freedland, Clouse, & Lustman, 2001; Moussavi et 
al., 2007). Marrie and Horwitz (2010), suggest that among other factors, physical and 
mental comorbidities negatively impact MS by delaying MS diagnosis, increasing 
disability, and decreasing HRQoL. Several studies that identified the presence of 
depression as a comorbid condition in PwMS noted that the overall comorbid diseases are 
more common in older people with MS (>60 years) (Chwastiak et al., 2002; Marrie et al., 
2008). However, no studies have specifically investigated comorbid diseases as a 
potential vulnerability factor for depression in older PwMS. It is, therefore, crucial for 
healthcare professionals to pay close attention to such co-occurring diseases in older 
PwMS as a risk factor for developing depression.  
2.2a.viii Early Retirement 
 The CBC news reported that according to Statistics Canada, the average age of 
retirement of Canadians rose from 61 in 2005 to 63 in 2015 (MacNaughton, 2016). In the 
last 10 years, one in every eight Canadian senior citizens (i.e., over 65 years old) is still 
employed compared to ten years ago, when one in 13 Canadian were employed. It 
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appears that over the last decade there is an increase in the number of older adults that are 
still active members of the workforce. Then, will there be a negative impact on those 
older adults if they were to retire early (i.e. before they are 65) due to chronic disease? 
Early retirement is the practice of leaving one’s employment before the statutory 
age (i.e., most often 65 years) (Canada Pension Plan, 2016). Usually, the term has 
positive connotations, representing a favourable financial status. However, this is not 
always the case for those who take early retirement due to chronic illness (Gallo, Bradley, 
Siegel, & Kasl, 2000). In Canada, accepting an early retirement has inherent negative 
financial consequences. An individual who starts receiving their Canada Pension Plan 
retirement pension at the age of 60 receives 36% less money than if they take it at 65 
years (Canada Pension Plan, 2016). Therefore, those individuals who are required to 
retire before 65 may face significant financial strain if they need to rely on their pension 
for medical or day-to-day expenses. According to Quine, Wells, De Vaus, and Kendig 
(2007), the choice of retirement, rather than a requirement, helps in retirement planning 
and better adjustment to retired life. A mental health survey conducted on 35,015 
individuals by Noorbala, Yazdi, Yasamy, and Mohammad (2004), reported that 
prevalence of mental disorder (e.g., depression and anxiety) was found to be greater in 
individuals who were retired or unemployed than those who had an employment. 
Although early retirement (i.e., forced early retirement due to a chronic illness) and 
unemployment are two different aspects, they can still have a significant negative impact 
on mood due to the sheer inability to have a job. Unless a person has good benefits and 
retirement plans, early retirement poses constraints on one’s socio-economic status and 
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financial condition that may lead to depression (Wang et al., 2010). On the other hand, 
Oksanen et al. (2011) demonstrated some benefits of early retirement on mental health 
noting that the retirees used fewer antidepressants during their transition period. Some 
other studies have also shown that voluntary retirement has positive effects on 
individuals’ physical and mental well-being, which may not be the case for involuntary 
retirement (Shultz, Morton, & Weckerle, 1998). It appears that much attention was paid 
to the impact of early retirement on mental health, but studies did not investigate early 
retirement or forced retirement due to chronic disease as a risk factor for depression in 
older adults. 
According to Shih, Wu, Wakeford, and Lakdawalla (2016), the single most 
common cause of forced unemployment or early retirement in PwMS is the 
unpredictability of MS that affects the overall disability in these individuals. PwMS have 
also reported that physical and neurological changes are other important reasons for early 
retirement (Smith & Arnett, 2005). Many studies demonstrated that PwMS often seek 
early retirement from their employment which leads to social isolation and decreased 
overall quality of life, which may further impact their self-worth (Aronson, 1997; Kobelt 
et al., 2006; Miller & Dishon, 2006; Pfleger, Flachs, & Koch-Henriksen, 2010). The 
impact of early retirement and/or unemployment due to MS has not been broadly 
researched, but there is some evidence that suggests a bidirectional relationship between 
early retirement and depression in PwMS (Karpansalo et al., 2005; Leino-Arjas, Liira, 
Mutanen, Malmivaara, & Matikainen, 1999).  
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Various studies on older adults encourage individuals to find age-appropriate jobs 
and apply for benefits for early retirement due to disability (Rice, Lang, Henley, & 
Melzer, 2011). This is because early retirement impacts the overall financial condition of 
a family as much as it affects individual’s income. Two studies in the general population 
that used data from the Health and Retirement Survey (HRS) to examine mental health 
impacts of job loss among older adults reported an increase in depressive symptoms after 
job loss (Gallo et al., 2000; Siegel, Bradley, Gallo, & Kasl, 2003). Another cross-
sectional study on 13,186 PwMS between ages 45 and 53 years, reported that 
approximately 33% to 45% of the sample retired early due to MS (Kobelt et al., 2006). 
From an economic perspective, both primary care and mental health patients show 
reduced productivity and more frequent use of healthcare services, which ultimately 
increase financial burdens of the society (Karpansalo et al., 2005).  
It is difficult to compare results from different countries such as the UK, 
Australia, Europe and North America because the legislation surrounding pension for 
disability and early retirement are different in different countries. However, research 
worldwide has shown that MS often causes early occupational disability which forces 
individuals to seek early retirement from their employment (Kobelt et al., 2006; Miller & 
Dishon, 2006). Studies have alluded to the occupational difficulties faced by PwMS, and 
the ordeals of receiving an early pension (Pfleger et al., 2010). But studies have not yet 
considered the impact of early retirement as a potential risk factor for developing 
depression in PwMS. As such, clinicians should not overlook early retirement due to MS 
which is a potential marker for the development of depression. 
PREDICTORS OF DEPRESSION IN MS 
42 
 
 The factors stated above provide a reason for the need to understand predicting 
factors of depression. Healthcare professionals will be able to use these variables as 
possible “rule outs” or “vulnerabilities” that make older adults with MS more at risk of 
developing depression. Policymakers can advocate for continuous supportive therapy for 
older people who live in one or more of these vulnerable conditions. Better awareness 
also increases treatment adherence in PwMS that will ultimately contribute to healthy 
living and healthy aging in older PwMS.  
2.3 Significance of the study 
Throughout the literature, researchers have explained the difficulties related to MS 
and the impossibility of completely curing this disease (Goodin et al., 2002). As such, it 
was suggested that the management of MS-related symptoms should focus on reducing 
physical, emotional/psychological, social and cognitive difficulties as imposed by MS. 
Depression is one of the most common psychological problems faced by PwMS 
(Andrade, 2011; Feinstein et al., 2014). Depression worsens MS symptoms, affects other 
comorbid diseases, slows down recovery process of MS, and interferes with an 
individual’s motivation for treatment (Marrie & Horwitz, 2010; Marrie, Reider, et al., 
2015; Marrie, Reingold, et al., 2015; Sahakyan et al., 2013; Stein-Shvachman et al., 
2013). As such, the main aim of our study is to explore the independent predictors of 
depression in older adults with MS. Understanding the predictors of depression will help 
clinicians regularly screen for depression by using self-report measures and clinical 
interviews for those who report potential risk-factors of depression. Kennedy (2002) 
stated that full remission of depression is achievable through evidence-based therapy 
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and/or medication. However, therapy and medication for depression also add to the 
already existing economic burden for PwMS. Therefore, another possible reason for 
exploring and understanding the elements the risk factors for depression may be to screen 
individuals, conduct assessment, and provide treatment to those in need. This may 
ultimately reduce the potential worsening of MS symptoms and help lessen economic 
burden. The findings of this research will be able to make a significant contribution to the 
existing body of literature with respect to the risk-factors of depression in older PwMS. 
To find the independent predictors of depression, an exhaustive literature search 
was done on the association of depression with various demographic and clinical 
variables in general population, primary care population, PwMS, and older adults. After a 
thorough literature search, variables were selected apriori. While doing the literature 
search, it was observed that several studies demonstrated the difficulties related to 
differentiating the symptoms of MS and depression due to the overlap of neurological and 
psychological symptoms of the two diseases (Feinstein et al., 2014; Galeazzi et al., 2005). 
Therefore, we decided to use two separate depression constructs that were available in the 
data set particularly to understand if there were any differences between depressed and 
non-depressed PwMS on various demographic and clinical variables when they reported 
being diagnosed by a medical professional and when they self-reported depressive 
symptoms on a depression questionnaire (HADS-D). Therefore, as a first step, we wanted 
to find the prevalence rate of depression as diagnosed by medical professionals. 
Following that we wanted to explore if there is a difference between depressed and non-
depressed participants on demographic and clinical variables when participants reported 
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being diagnosed with depression by their medical professional. Secondly, we wanted to 
find the prevalence rate of depression as when participants self-reported symptoms on the 
HADS-D. Following that, we wanted to explore if there is a difference between depressed 
and non-depressed participants on demographic and clinical variables when participants 
self-reported symptoms on the HADS-D. After the exploration process, all those variables 
that were significantly different for both medically diagnosed depression and self-
reported depressive symptoms were carried forward to the main predictive model as 
potential predictors of depression.  
For the predictive model, this study used a stringent technique to screen 
individuals for depression. Those participants who reported being diagnosed by medical 
professional as well as self-reported depressive symptoms on the HADS-D formed the 
“depressed” group. The “non-depressed” group consisted to those participants who either 
reported being diagnosed with depression by their medical professional, or scored above 
the cut-off on the HADS-D or did not have either of the two. As discussed in the above 
paragraph, the predictive variables were carried forward from the exploratory analyses as 
those that had a significant association with medically diagnosed depression or self-
reported depressive symptoms.   
2.4 Hypothesis 
 Depression is a common emotional problem in PwMS (Feinstein et al., 2014). 
Depressive symptoms are sometimes difficult to identify from the symptoms of MS due 
to significant neurological and psychological symptoms overlap between the two diseases 
(Feinstein et al., 2014; Galeazzi et al., 2005). Exploring predictors of depression in older 
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PwMS will add to the preventative measures taken by PwMS, clinicians and community 
support workers to understand the risk-factors of depression.  
Prediction: The same variables will not be significantly different in depressed and 
non-depressed participants when depression is assessed by a medical professional as 
reported by participants and when depression is assessed by a self-report questionnaire 
during the survey. We also hypothesize that the following personal and disease-related 
factors: gender, age, financial condition, early retirement due to MS, social support, 
number of years living with MS, physical comorbidities, physical disability and perceived 
disability are the independent predictors of depression in older PwMS.  
Research Question 1: What is the prevalence rate of depression as diagnosed by 
medical professionals? Is there a difference between depressed and non-depressed PwMS 
on demographic and clinical variables when they reported being diagnosed with 
depression by their medical professional?  
Research Question 2: What is the prevalence rate of depressive symptoms as 
measured by HADS-D during the survey? Is there a difference in PwMS between those 
with and without depressive symptoms on demographic and clinical variables when 
assessed by HADS-D?  
Research question 3: What are the independent predictors of depression in older 
PwMS.  
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Chapter 3 
Methods 
3.1 Introduction 
This cross-sectional epidemiological study employs secondary analysis of de-
identified data gathered between May 2011 and December 2012 as part of the “Health, 
Lifestyle and Aging with MS” survey (HREB#10.06) (Ploughman, Beaulieu, & Harris, 
2015). The complete methodology and initial results of the survey are already published 
elsewhere (Ploughman, Beaulieu, et al., 2015; Ploughman et al., 2014).  
Firstly, we aim to explore the prevalence of depressive symptoms in this 
population through various sources (e.g., diagnosis of depression provided by a medical 
professional, and self-reported depressive symptoms as measured by HADS-D during the 
survey). We hope to gain a more vivid picture of the presentation of depression in this 
population both in terms of medically diagnosed depression and self-reported depressive 
symptoms. We also wish to explore if there were significant differences between 
depressed and non-depressed participants on various clinical and demographic variables. 
Analyses will be run separately for depressed and non-depressed group when they 
reported being diagnosed by a medical professional and when they self-reported 
depressive symptoms on the HADS-D. Finally, we wish to explore the independent 
predictors of depression in older PwMS. Variables were selected apriori after a thorough 
literature search on studies that identified predictors of depression in young and old 
PwMS, general population, and in other chronic conditions (Siracusano, Niolu, Sacchetti, 
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& Ribolsi, 2013). The personal factors chosen as predictors were gender, age, social 
support, and financial condition and MS-related factors were number of years living with 
MS, physical disability, perceived disability, early retirement due to MS, and comorbid 
physical conditions.  
3.2 Initial Survey Design 
(Health, Lifestyle and Aging with MS survey) 
The survey consisted of validated self-reported outcome tools. Additional custom-
designed questions were chosen based on pilot research in a small sample of older PwMS 
(Ploughman et al., 2012). Utilizing the participant feedback that was received from the 
smaller sample, a paper version of the survey was tailored to the potential needs of an 
older population. The revisions to the new survey included larger font size and dividing 
the survey into six sections (chapters) that grouped similar questions together: You and 
Your MS (5 pages); Your Health (6 pages); Your Activities (8 pages); Your Thoughts and 
Feelings (7 pages); Your Social Life (4 pages); Your Opinions (1 page) (see Appendix 4). 
This was done to avoid survey fatigue, and instructions were provided for respondents 
that suggested that they complete the survey in sections (i.e., chapters) taking a break in 
between. In order to examine the feasibility and user-friendliness of the survey and to 
minimize skipped items, the first 14 participants (11 returns) were asked to provide 
feedback on the content, format, and response burden. The 11 responses were not 
included in the final data, but their feedback was integrated into the final version of the 
questionnaire.  
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The initial study was approved by 11 health research ethics boards in eight 
Canadian provinces: British Columbia, Alberta, Manitoba, Saskatchewan, Ontario, 
Quebec, Nova Scotia, and Newfoundland and Labrador. Participants in the initial study 
were recruited from a list generated from the MS databases in the eight provinces 
including sub-sites in Prince Edward Island and New Brunswick. In order to include 
PwMS from the province of Quebec, Canada, the entire survey including the cover letter 
was translated into French by one independent professional translator. French versions of 
previously validated tools were also obtained for those participants. Four native French 
speakers involved in MS research made corrections to the initial translation. The revisions 
were then consolidated by a fifth French-speaking MS researcher. A total number of 921 
PwMS were contacted for the research study of which 743 returned the completed survey 
(Ploughman et al., 2012).  
The complete survey consisted of a total of 147 questions all of which self-
reported questions from standardized tools except for the last two questions were that 
were open-ended questions (see Table 1). Where needed, permission was obtained from 
the developers of the validated tools to use in the survey.  
Table 1: Variables and Measure of the Initial Survey (entire questionnaire) 
Chapter Domains Measurement Tools 
1. You and 
Your MS 
(5pages) 
Demographics 
Postal code, gender, height, weight, age, 
finances and education 
 MS Disease 
Characteristics 
Symptom onset, time since diagnosis, and 
type of MS 
Environment 
Living situation, accessibility and home 
modifications 
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2. Your Health 
(6pages) 
Health-Related 
Quality of Life 
Visual analogue scale of perceived health 
status 
Multiple SclerosisImpactScale-20 
Physical Health and 
Disability 
Barthel Index 
Comorbidity Questionnaire 
HealthCare Services 
Use and satisfaction with healthcare 
services, medications and 
complementary/alternative health. 
   
3. Your Activities 
(7pages) 
Participation and 
Instrumental 
Activities of Daily 
Living 
Frenchay Activities index; Employment 
and impact of fatigue 
Lifestyle 
Simple Lifestyle Indicator Questionnaire 
(diet, exercise, stress, smoking, alcohol)  
4. Your Thoughts 
and Feelings 
(8pages) 
Mental/Cognitive 
Health 
Hospital Anxiety and Depression Scale 
(HADS) 
Resilience Scale 
Problems with concentration and memory 
   
5. Your Social 
Life 
(4pages) 
Social Support Personal Resource Questionnaire-2000 
   
6. Your Opinion 
(1 page) 
Open-ended question 
From your point of view, what are the 
most important things that help you live 
long and healthy with MS? 
If you would like to make any final 
comments about this questionnaire or the 
study itself, please record them in the 
space provided below. If you need more 
space for writing, feel free to attach an 
additional piece of paper.  
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3.3 Sample Population 
743 Canadians of age 55 years or older with self-reported MS symptoms for 20 
years or more comprised the sample of the initial study. During the data collection 
process in the initial survey, participants were recruited by contacting them via telephone 
from lists of eligible MS clinics, public advertising through the MS Society of Canada 
Research Internet, local MS Society chapters and their newsletters, and newspaper 
advertisements. A confirmed diagnosis from a neurologist was available for participants 
who were recruited through the MS clinic databases. Self-identified participants provided 
a diagnosis date and name of their neurologists to confirm their diagnosis. 
3.4 Data Collection Process of the Initial Study 
Ploughman and colleagues (2014) collected a large nationally representative 
sample, and the researchers regularly followed up at various study sites and made formal 
and informal contacts with MS Society Chapter support groups. Consent was obtained 
using a standard script, following that, the questionnaire was mailed to participants. The 
questionnaire package consisted of the information sheet, a toll-free telephone helpline 
number and email address, and a prepaid reply envelope (see Appendix 2). Participants 
were requested to return the completed survey within 2 weeks, and non-responders were 
telephoned for a reminder at 4 weeks mark. Participants were also encouraged to 
complete the survey by telephone who wished to do so. Each questionnaire was coded to 
maintain anonymity. 
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3.5 Present Study 
This present study (i.e., the dissertation) was approved by the Health Research 
Ethics Authority (HREA # 14.103), Newfoundland and Labrador to use the data for 
secondary analysis. The participants’ demographic composition of this present study was 
the same as the initial survey conducted by Ploughman and her colleagues. 743 
Canadians, 55 years or older living with self-reported MS symptoms for 20 years or more 
formed the sample population of this study. 
3.6 Instrument Description for the Present Study 
This section described only those variables and instruments that were used in this 
present study (see Table 2).  
Table 2: Variables used in the Present Study 
Variables Measure 
Survey 
Question 
Number of 
Items 
Demographics 
Gender 
Age 
Province 
Financial Condition 
Early Retirement due to MS 
2 
3 
1 
12 
80 
2 
1 
1 
3 
2 
MS disease 
Type of MS 
Comorbidity 
18 
49 
7 
32 
 
Affect/Mood 
Hospital Anxiety and Depression 
Scale (Depression)- HADS-D 
 
Depression diagnosis by medical 
professional  
 
104, 106, 108, 
110, 112,114, 
116 
49 (first 
column, 4
th
 
item) 
7 (4 options in 
each item) 
 
1 
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Antidepressant                                                          62                                            1 
 
Disability 
Status 
Barthel Index- BI 
Multiple Sclerosis Impact Scale- 
MSIS 
 
51-60 
19-47 
10 
29 
Social Support 
Personal Resource Questionnaire- 
PRQ 
131-145 15 
 
 Demographics 
Gender
1
 
The gender of the participants was collected as a part of the “you and your MS” 
section to gather participant’s demographic information. The researchers recorded the 
gender of the participants as male or female. Gender was coded as: 0 = “Female” and 1 = 
“Male” (see Appendix 1). 
Age 
Age was calculated by asking participants to enter their year of birth. During data 
entry, age was calculated by subtracting their year of birth from the year 2012. Groupings 
and coding for ‘age’ are available in (see Appendix 1). 
 
 
                                                          
1
 The original survey uses the term ‘gender’ to differentiate between male and female respondents in 
terms of biological sex.   
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Province 
 Province was determined by the asking the participants to write their postal code 
(see Appendix 1).   
Financial Condition 
Financial condition was suggested through three items that asked the participants 
about their opinion (i.e., perception of their financial status) on whether they think they 
have enough, just enough, or do not have enough money to meet their daily needs so that 
they can live the way they want. During data entry, financial condition was coded and 
grouped according to participants’ responses. The three groups were re-coded into two 
categories with “do not have enough money” classified as “0 = do not have money” and 
“have enough and just enough” money classified as “1 = have money” (see Appendix 1). 
Primary Outcome 
Depression diagnosis as provided by medical professional 
Participants were presented with a list of health conditions based on a comorbidity 
index by Horton, Rudick, Hara-Cleaver, and Marrie (2010) and they were asked to 
indicate the ones that they were diagnosed with by a healthcare professional. Depression 
was one of the health conditions on the list. In order to categorize individuals with and 
without depression, the item that asked participants if they were medically diagnosed with 
depression was selected, and the total sample was classified into two groups (0 = no 
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diagnosis of depression; 1 = diagnosis of depression). Coding for this variable is available 
in Appendix 1. 
Self-reported depression: Hospital Anxiety and Depression Scale (HADS) 
Literature highlights that symptoms of depression and anxiety are common in 
PwMS and they affect a person’s QoL from every aspect. There are numerous self-report 
measures designed to detect mood and anxiety symptoms in the general population, 
psychiatric samples as well as for patients with medical or neurological disorders.  
Honarmand and Feinstein (2009) noted that many self-report measures for psychiatric 
diagnosis that are administered on primary care clients do not always consider the 
importance of somatic confounders like fatigue, sleep and appetite, and impaired 
concentration. They explained that the somatic symptoms might be attributed to both 
primary care and psychiatric conditions which may inflate the total score.  
The Hospital Anxiety and Depression Scale (HADS) is a 14 item self-report 
measure that detects anxiety and depression and takes somatic confounders into account 
(Zigmond & Snaith, 1983). HADS is validated for the use in medical settings with PwMS 
and other chronic conditions (Al-Gamal, 2015; Bratas, Gronning, & Forbord, 2014; 
Honarmand & Feinstein, 2009; Paker, Bugdayci, Midik, Celik, & Kesiktas, 2013; 
Rodriguez-Blazquez et al., 2009). Predetermined cut-off scores group patients into 
normal (0 – 7), mild (8 – 10), moderate (11 – 14) and severe (15 – 21) ranges of 
depression or anxiety separately. Scores for the entire scale (depression and anxiety) 
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range from 0 to 42, with higher scores indicating more distress due to depression and/or 
anxiety (Zigmond & Snaith, 1983).  
HADS has been validated across different counties and cultures (Bocerean & 
Dupret, 2014; Hinz et al., 2014; Roberts, Fletcher, & Merrick, 2014) and has also been 
translated into various popular languages (e.g., Spanish, French) (Lane et al., 2007). In 
the validation study by Honarmand and Feinstein (2009), the threshold score of 8 or 
higher on the depression subscale provided a sensitivity of 90% and specificity of 87.3%. 
In this study, the seven items that assessed the presence of depression from the total 14 
items on HADS was considered and was called the Hospital Anxiety and Depression 
Scale-Depression component (HADS-D). A score of 7 or lower on the HADS-D was 
considered as participates with no depressive symptoms, and a score of 8 or higher was 
defined as participants with depressive symptoms (Bjelland, Dahl, Haug, & Neckelmann, 
2002). Presence of depression was coded as “0 = No Depressive Symptom” and “1 = 
Depressive Symptom” (see Appendix 1). 
There are several advantages in using HADS as it works well with both medical 
and non-medical populations and it is a brief measure that takes no more than 5 minutes 
to complete (Christodoulou et al., 2010; Snaith, 2003). It requires participants to report 
their feelings in the past week and can be re-administered after a week’s time. HADS-D 
formed one of the main research questionnaires for this present study that determined if 
participants had self-reported depressive symptoms above the cut-off point (i.e. ≥ 8).  
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Clinical Variables 
Physical Disability: Barthel Index (BI) 
Although there are various measures of disability in MS, there are no clinical 
scales that are universally accepted for use in PwMS (Sharrack & Hughes, 1996). The 
most widely used and popular tool for measuring disability status in PwMS has been the 
Expanded Disability Status Scale (EDSS) (Kurtzke, 1983). However, one of the 
limitations of the EDSS is that it is based on neurological examination and not functional 
limitations and is a clinician-administered instrument. Therefore, the Barthel Index (BI) 
was developed to measure the extent of someone’s independent functioning and mobility 
in their ADL out of the limitations posed by EDSS (Laake et al., 1995). The BI measures 
activities like feeding, bathing, grooming, dressing, bowel control, bladder control, 
toileting, chair transfer, ambulation and stair climbing. The index also reports the need for 
assistance in PwMS. This index was initially developed for use in hospital-based 
rehabilitation patients with neuromuscular difficulties and stroke (Laake et al., 1995). BI 
is the most widely used assessment to measure disability in terms of difficulties with 
ADL and functional limitations (Mahoney & Barthel, 1965; van der Putten, Hobart, 
Freeman, & Thompson, 1999). 
The BI was first developed by Mahoney and Barthel in 1965 and later modified by 
Collin, Wade, Davies, and Horne in 1988 (Collin, Wade, Davies, & Horne, 1988; 
Mahoney & Barthel, 1965). Formiga, Mascaro, and Pujol (2005) found a high inter-rater 
reliability of the overall BI score (r =0.793) with older adults (mean age 72.6 (±11)) but 
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they also found that the inter-observer scores on subscales like feeding, grooming and 
transfers were not as high (kappa<0.4).  
The original version is a 10-item instrument with the following categories: 
feeding, bathing, grooming, dressing, bowel control, bladder control, toileting, chair 
transfer, ambulation and stair climbing (Mahoney & Barthel, 1965). Items are scored as 0, 
5, and 10 depending on the amount of assistance needed to do the above activities, or 
whether individuals can do them independently. BI is scored from 0 – 100, with a higher 
score indicating greater independence. Shah, Vanclay, and Cooper (1989) suggested that 
scores of 0-20 indicate “total dependence”, 21-60 indicate “severe dependence”, 61-90 
indicate “moderate dependence”, 91-99 indicates “slight dependence”, and 100 indicates 
“independence”. Lewis and Shaw (2017) noted that most studies use a 60/61 cutting 
point. In this present study, scores on BI are used on a continuous scale with lower scores 
indicating more dependence.  
Perceived Disability: Multiple Sclerosis Impact Scale (MSIS-29) 
There are several valid and reliable measures used to assess disability status in 
PwMS. However, most tools assess functional ability and limitations in PwMS to be able 
to understand the progression of MS (Giordano et al., 2009). These popular clinical tools 
are nonetheless unable to holistically evaluate the effects of MS on an individual’s 
physical and psychological functioning. MSIS-29 is a 29-item condition-specific, self-
report questionnaire that is geared towards measuring the individual’s view on the impact 
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of MS on their HRQoL, their everyday functioning, and their perceived levels of 
disability posed by MS (Giordano et al., 2009).  
MSIS-29 is divided into two subscales: a 20-item physical impact scale and a 9-
item psychological impact scale. Scores on the physical impact scale can range from 20 to 
80 and on the psychological impact scale from 9 to 36. Lower scores on the MSIS-29 
indicate less impact of MS, while higher scores indicate a more significant effect of MS 
(Riazi, Hobart, Lamping, Fitzpatrick, & Thompson, 2002). The validity, reliability and 
consistency of the psychometric properties of the MSIS-29 have been established in 
different settings by various researchers (Riazi et al., 2002). The MSIS-29 was created 
based on qualitative interviews with PwMS following a thorough evaluation and 
employed both traditional and modern psychometric approaches (Hawton, Green, 
Telford, Zajicek, & Wright, 2012; Hobart & Cano, 2009; McGuigan & Hutchinson, 
2004). 
Social Support: Personal Resource Questionnaire (PRQ) 
The PRQ scale is used to measure the participants’ social support. The PRQ 
consists of 15 short statements on a seven-point Likert scale (from 1-Strongly Disagree to 
7-Strongly Agree). The participants report the degree to which they agree or disagree with 
each statement. Higher scores on the PRQ indicate higher levels of social support 
(Weinert and Brandt, 1987). According to Weinert and Brandt (1987), the formation of 
the PRQ was based on five underlying concepts: one is valued (worth), one is an integral 
part of a group (social integration), the provision for attachment/intimacy (intimacy), 
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opportunity for nurturance (nurturance), and availability of informational, emotional and 
material help. The PRQ demonstrates good content, predictive and construct validity 
(Brandt & Weinert, 1981; Weinert, 1984). In a systematic review, Tawalbeh and Ahmad 
(2013) reviewed nine studies that used PRQ and reported that the internal consistency 
raged between 0.87 to 0.93 and provided positive evidence for construct validity when the 
PRQ was used in relation with various study variables including disability, loneliness, 
depression, stress, pain and so on. The researchers also noted the diverse demographic 
composition in terms of age, socioeconomic status, ethnicity and educational level that 
were used in the different studies. Fong, Finlayson, and Peacock (2006) reported the use 
of PRQ to measure social support in PwMS.   
Early Retirement due to MS 
 This is a single item that was extracted from the tool called the Frenchay 
Activities Index (FAI) that inquired about an individual’s level of participation in 
productive work and instrumental activities of daily living, and their employment status 
(Nouri & Lincoln, 1987). The statement asked participants to answer in “yes” or “no” if 
they had to retire early or had to stop working because of MS. Early retirement due to MS 
was coded as 0 = no and 1 = yes (see Appendix 1).  
Type of MS 
According to the National MS Society (2015), there are four main types of MS 
(Primary-Progressive, Secondary-Progressive, Relapsing-Remitting and Progressive-
Relapsing) and they have been categorized by the symptom manifestations. The two most 
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common types of MS are the relapsing-remitting followed by the primary-progressive 
type (Hooper 2011; & Tremlett, Yousefi, Devonshire, Rieckmann, & Zhao, 2009). As 
such, only these two types were considered in the analysis (see Appendix 1). 
Number of years living with MS diagnosis 
Participants were asked to indicate the year when they were officially diagnosed 
with MS by a healthcare professional. During data entry, time since MS diagnosis was 
calculated by subtracting their reported year of official MS diagnosis from the year 2012. 
Groupings and coding for this variable is available in (see Appendix 1). 
Physical Comorbidities 
 Participants were provided with a list of possible comorbid conditions that were 
determined through Marrie and Horwitz’s Comorbidity Questionnaire (Marrie & Horwitz, 
2010). Conditions such as anxiety disorder, bipolar disorder and depression did not form 
a part of this variable. All the other conditions were considered.  
Antidepressant 
Antidepressants are psychiatric medications that are given to people with mood 
disorders to alleviate their symptoms. However, it must be noted that antidepressants may 
also be used for other psychiatric conditions besides depression, for example, anxiety 
disorders. At the same time, some other psychotropic medications like antiepileptic drugs 
that were prescribed to PwMS in this population may also alleviate mood-related 
symptoms. Participants were asked to provide names of all the drugs that they were 
currently taking for MS and other health conditions. Antidepressants were noted, and the 
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number of participants taking antidepressants was counted in order to know the sample 
size of people who were diagnosed with depression and had been taking medication for 
depression.  
3.7 Data Analysis 
Data analyses were performed using IBM SPSS (Statistical Package for the Social 
Sciences) V. 21 software. As a first step, test for normality was run. Then, descriptive 
statistics were used to explore demographic and clinical characteristics of the population 
in terms of depression diagnosed by a healthcare professional (i.e., medically diagnosed 
depression), and self-identified depressive symptoms as measured by HADS-D.  
Individuals with and without a diagnosis of depression, and self-reported 
depressive symptoms were compared based on various demographic and MS-related 
variables. Based on previous research a list of ‘a priori’ factors that are potentially 
associated with depression in older PwMS was categorized into two domains; (1) 
demographic, and (2) clinical. Demographic information included age, gender, years of 
education, social support (PRQ), current financial condition, province of individual, 
living situation, current employment status, and early retirement due to MS. Clinical 
factors included type of MS, number of years living with MS, self-reported depression, 
using antidepressant, physical comorbidities, physical disability (BI), and perceived 
disability (MSIS).  
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From the above-mentioned factors, the continuous variables were analyzed using 
independent samples t-tests, and the categorical variables were analyzed using chi-square 
tests. 
An alpha level of .05 was used for determining significance. The alpha level of 
.05 was set based on the following explanation provided by Cramer and Howitt (2004), 
“The level at which the null hypothesis is rejected is usually set as 5 or 
fewer times out of 100. This means that such a difference or relationship is likely 
to occur by chance 5 or fewer times out of 100. This level is generally described 
as the proportion 0.05 and sometimes as the percentage 5%. The 0.05 probability 
level was historically an arbitrary choice but has been accepted as a reasonable 
choice in most circumstances. If there is a reason to vary this level, it is acceptable 
to do so. So, in circumstances where there might be very serious adverse 
consequences if the wrong decision were made about the hypothesis, then the 
significance level could be made more stringent at, say, 1%” (p. 151). 
Various studies discussed the difficulties related to diagnosing depression due to 
overlapping of symptoms with MS when a self-reported measure is used to assess 
depression (Feinstein et al., 2014; Gunzler et al., 2015). For this reason, we wanted to 
examine if there was a difference between depressed and non-depressed PwMS in terms 
of demographic and clinical variables when their depression is diagnosed by a medical 
professional versus when depression is assessed by self-reported questionnaire. For the 
first instance, depression, as diagnosed by a medical professional, the item on the 
comorbid disease list that enquired about a participant’s diagnosis of depression was used 
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to create the first outcome measure (i.e., medically diagnosed depression). We classified 
respondents into ‘No Diagnosis of Depression’ or ‘Diagnosis of Depression.’ The first 
research question explored differences in the demographic and clinical factors between 
those who were medically diagnosed with depression and those who were not. For the 
second outcome measure, self-reported depressive symptoms as measured by HADS-D 
cut-off score (≥8) was used, and the total sample was classified as ‘No Depressive 
Symptoms’ or ‘Depressive Symptoms.’ Individuals whose scores were 7 and below were 
considered sample without self-reported depressive symptoms and individuals whose 
score were 8 and above, were considered sample with self-reported depressive symptoms. 
The second research question explored differences in the demographic and clinical factors 
between those who met the cut-off criteria on the HADS-D and those that did not.  
Independent samples t-tests were run to analyze if there is a significant difference 
between depressed and non-depressed PwMS when the were diagnosed with depression 
by a medical professional with respect to the following variables: age, total years of 
education, total number of physical comorbidities, number of years living with MS, social 
support, physical disability, and perceived disability. Separate independent samples t-tests 
were run with the same independent variables in order to analyze if there is a significant 
difference between individuals who self-reported depressive symptoms and those who did 
not. All t-tests were also subjected to Levene’s Test of Equality of Variances.  The 
variables that were statistically significant on the Levene’s Test for Equality of Variances 
indicated that group variances were unequal. As such, in order to correct the violation, 
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non-pooled variances and Welch-Satterthwaite adjusted degrees of freedom were used for 
comparison purposes.   
A chi-square test was run to analyze if there is a significant difference between 
participants who reported being diagnosed with depression by their medical professional 
versus those who did not. The categorical variables selected apriori are: gender, living 
situation, current financial condition, type of MS, total years of education, use of 
antidepressant, employment status, early retirement due to MS, and province of 
individuals. A separate chi-square test was run with the same categorical variables in 
order to analyze if there is a significant difference between individuals who self-reported 
depressive symptoms and those who did not. Odds ratio was calculated for those variables 
had a significant relationship with medically diagnosed depression and/or self-identified 
depressive symptoms. 
A Pearson’s Correlation analysis was done to explore the significant relationships 
between depression (i.e., self-reported depressive symptoms and medically diagnosed 
depression) and the study variables (i.e., age, gender, early retirement due to MS, 
financial condition, number of years living with MS, physical comorbidity, social 
support, perceived disability and physical disability) in older PwMS. 
A Bonferroni correction was not conducted for the initial two t-tests as they were 
entirely performed as an exploratory method to find the demographic and clinical 
variables (on a continuous scale) that were in someway significantly different in 
depressed and non-depressed participants. The significant variables were then carried 
forward to the confirmative predictive model. A stringent correction in the first step may 
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not have helped in including all possible variables for the confirmative predictive 
analyses as the variables would have deviated further away from the 0.05 level. 
Moreover, it would have increased false negatives (type II error rate) (Cohen, 1994). 
The clinical and demographic variables were selected apriori after an exhaustive 
literature search in terms of association of the above variables with depression in the 
general population, primary care population, in PwMS, and in older adults. The t-tests 
and chi-square tests were used to explore those significant variables connected to self-
reported depressive symptoms and medically diagnosed depression. Following the t-tests 
and chi-square analyses, all those demographic and clinical variables that had a 
statistically significant or trending relationship with depression (as determined by p-
values < .05) (i.e., depression diagnosed by medical professional or HADS-D) were then 
carried forwards to examine the independent predictors of depression in older PwMS. 
Given the difference between the two ways of defining depression (i.e., medically 
diagnosed depression and self-reported depressive symptoms), information from both 
classifications is used to define ‘Depression’ in the final analysis. To create the final 
outcome for the predictive model, those participants who reported that they had been 
diagnosed with depression by their medical professional as well as self-identified as 
having depressive symptoms were classified as ‘Depressed’ and those who did not have a 
depression diagnosis or did not self-identify depressive symptoms were classified as 
‘Non-depressed.’ This means that only those participants who had a diagnosis of 
depression as well as scored ≥8 on HADS-D formed the sample for the final analysis. The 
resulting classification provides for a clearer distinction between those who are or are not 
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depressed.  ‘Non-depressed’ participants were coded as 0, and ‘Depressed’ participants 
were coded as 1. Since the dependent variable is binary in nature, a logistic regression 
model was used to estimate the risk factors for depression.  
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Chapter 4 
Results 
4.1 Overall Demographic and Background Characteristics 
Of 743 potential participants, 577 were women and 166 were men, and they were 
between the ages of 55 and 88 years.  
4.2 Research Questions  
Research Question 1: What is the prevalence rate of depression as diagnosed by 
medical professionals? Is there a difference between participants who reported versus 
who did not report being diagnosed with depression by their medical professional in 
terms of demographic and clinical variables?  
A chi-square analysis showed that 191 (25.7%) participants reported receiving a 
diagnosis of depression from their medical professional.  
Upon conducting the independent sample t-test, the Levene’s Test for Equality of 
Variances was statistically significant, for perceived disability, and number of physical 
comorbidities indicating that the group variances were unequal in this population. 
Therefore, the t-tests for these comparisons used non-pooled variances and Welch-
Satterthwaite adjusted degrees of freedom (see Table 3).  The analysis showed that 
participants who did and did not report receiving a diagnosis of depression from their 
medical professional did not differ on some demographic and clinical variables such as 
age, t(741) = 1.39, p = .164, Cohen’s d = 0.1; total years of education, t(741) = -1.08, p = 
.281, Cohen’s d = 0.08; physical disability, t(741) = 1.13, p = .259, Cohen’s d = 0.08; and 
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number of years living with MS, t(741) = 1.10, p = .273, Cohen’s d = 0.08. It was 
however also noted that participants who did and did not report receiving a depression 
diagnosis from their medical professional differed on many clinical and demographic 
variables such as total number of physical comorbidities, t(305.37) = -4.74, p < .0005, 
Cohen’s d = -0.54; social support, t(739) = 3.12, p = .002, Cohen’s d = 0.23; and 
perceived disability, t(295.67) = -4.12, p < .0005, Cohen’s d = -0.78. Therefore, 
individuals who were diagnosed with depression by their medical professional had more 
comorbid physical conditions, than those who did not have a diagnosis of depression. 
Participants self-reporting a depression diagnosis by their medical professional also had 
significantly lower social support than those who did not. Lastly, participants self-
reporting a diagnosis of depression by their medical professional perceived themselves as 
significantly more disabled than those who did not.   
Table 3: Descriptive Statistics: Demographics and clinical profile of depressed and non-
depressed participants according to the diagnosis provided by the medical professionals 
(N = 743) 
 
Demographics& 
Clinical Profile 
Total 
Population 
 No Diagnosis 
of Depression 
N = 552 
(74.3%) 
Diagnosis of 
Depression 
N = 191 
(25.7%) 
p 
 Mean (SD) Range Mean (SD) Mean(SD)  
Age 
64.62 (6.18) 55-88 64.81 (6.17) 64.08 (6.18)  
Total years of 
education 
13.47 (2.55) 5-25 13.41 (2.52) 13.64 (2.66)  
Number of years 
living with MS  
24.82 (10.02) 0-66 25.05 (10.06) 24.13 (9.89)  
Total number of 
Physical 
Comorbidities 
2.15 (1.87) 0-12 1.95 (1.79) 2.72 (1.97) *** 
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Social Support 
(PRQ) 
83.45 (16.87) 16-105 84.58 (16.48) 80.19 (17.6) ** 
Physical 
Disability (BI) 
76.17 (24.78) 0-100 76.78 (24.66) 74.42 (25.10)  
Perceived 
Disability 
(MSIS) 
77.96 (25.64) 29-140 75.7 (24.39) 84.48 (28.02) *** 
*p< .05. **p< .01. ***p < .001. 
Perceived Disability measured by MSIS- Multiple Sclerosis Impact Scale;  
Physical Disability measured by BI- Barthel Index;  
Social Support measured by PRQ- Personal Resource Questionnaire,  
Diagnosis of Depression as assessed by participants’ medical professional.  
A chi-square test of independence was used to determine if there was a significant 
relationship between individuals with and without a depression diagnosis on various 
demographic and clinical categorical variables. A significant effect was found between 
gender and depression, x
2
(1) = 4.63, p = .019; between early retirement due to MS and 
depression, x
2
(1) = 12.15, p = .007; and between self-reported depressive symptoms and 
depression diagnosed by a medical professional, x
2
(1) = 26.94, p < .0005.  
The chi-square analysis also showed that the percentage of participants who 
reported were diagnosed with depression by their healthcare professional did not differ by 
RRMS type, x
2
(1) = 3.28, p = .070; or by PPMS type, x
2
(1) = 2.54, p = .111. The 
percentage of participants self-reporting depression by their medical professional did not 
differ depending on type of home participants lived in and depression, x
2
(2) = 0.018, p = 
.991; use of antidepressant and depression, x
2
(1) = 0.04, p = .510; between current 
financial condition and depression, x
2
(1) = 1.77, p = .110; by province of the participant 
and depression, x
2
(10) = 17.46, p = .065; and current employment status and depression, 
x
2
(4) = 5.68, p = .224 (see Table 4). In terms of the odds ratio, it was found that the odds 
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were 0.63 times higher for a male participant to be diagnosed with depression than a 
female participant. Similarly, the odds were 4.62 times higher for a person who had to 
retire early due to MS to be diagnosed with depression than a person who did not have to 
retire early due to MS. Lastly, the odds ratio were 2.45 times higher for participants who 
reported receiving a depression diagnosis by their medical professional to also have 
higher than cut-off score on depression questionnaire as during the time of the survey.   
Table 4: Descriptive Statistics: Demographics, Disease Characteristics and Financial 
Characteristics of depressed and non-depressed participants according to the diagnosis 
provided by their medical professional (N = 743) 
 
Demographics, Disease 
& Financial 
characteristics 
Total Population 
No Diagnosis 
of Depression 
N = 552 
(74.3%) 
Diagnosis of 
Depression 
N = 191 
(25.7%) 
 
 N % N (%) N (%) p 
Gender      
Male 166 22.3 134 (24.3) 32 (16.8) * 
Female 577 77.7 418 (75.7) 159 (83.2)  
Relapsing-Remitting MS      
No 357 48 276 (50) 81 (42.4)  
Yes 386 52 276 (50) 110 (57.6)  
Primary-Progressive MS      
No 644 86.7 472 (85.5) 172 (90.1)  
Yes 99 13.3 80 (14.5) 19 (9.9)  
Self-Reported 
Depression 
     
No 514 69.4 410 (74.5) 104 (54.5) *** 
Yes 227 29.6 140 (25.5) 87 (45.5)  
Antidepressant        
Not Taking 706 95 524 (94.9) 182 (95.3)  
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One or more 37 5 28 (5.1) 9 (4.72)  
Living Situation      
House 716 96.4 532 (96.4) 184 (96.3)  
Assisted Living 
Complex 
16 2.2 12 (2.2) 4 (2.1)  
Long-term care facility 11 1.5 8 (1.4) 3 (1.6)  
Current Employment 
Status 
     
Unemployed 166 22.3 122 (22.1) 44 (23)  
Employed (Casual) 24 3.2 15 (2.7) 9 (4.7)  
Employed (part-time) 19 2.6 14 (2.5) 5 (2.6)  
Employed (full-time) 30 4 27 (4.9) 3 (1.6)  
Retired 504 67.8 374 (67.8) 130 (68.1)  
Early Retirement due to 
MS 
     
Yes 560 75.5 403 (73.1) 157 (82.2) ** 
No 182 24.5 148 (26.9) 34 (17.8)  
Current Financial 
Condition 
     
Have Money 578 77.8 436 (79) 142 (74.3)  
Do not have Money 165 22.2 116 (21) 49 (15.7)  
Province       
NL 48 6.5 36 (6.5) 12 (6.3)  
PEI 6 0.8 4 (0.7) 2 (1)  
NB 14 1.9 10 (1.8) 4 (2.1)  
NS 123 16.6 97 (17.6) 26 (13.6)  
QC 78  10.5 66 (6.3) 12 (10.5)  
ON 105 14.1 82 (14.9) 23 (12)  
MB 70 9.4 53 (9.6) 17 (8.9)  
SK 61 8.2 47 (8.5) 14 (7.3)  
AB 80 10.8 49 (8.9) 31 (16.2)  
BC 156 21 107 (19.4) 49 (25.7)  
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YK 2 0.3 1 (0.2) 1 (0.5)  
*p< .05. **p< .01. ***p < .001. 
 
Out of the 743 individuals who participated in the study, 552 (74.3%) of them 
were not diagnosed with depression by their medical professional and 191 (25.7%) 
individuals were diagnosed with depression (see Table 4).  
Four hundred and ten out of 552 non-depressed participants did not self-report 
symptoms of depression over the past two weeks during the time of the survey. One 
hundred and four participants out of the 191 participants who reported receiving a 
depression diagnosis by their medical professional, also self-reported depressive 
symptoms during the time of this survey. Two hundred and twenty-seven participants 
self-reported depressive symptoms on the depression questionnaire during the survey, but 
only 191 individuals reported receiving a depression diagnosis by their medical 
professional. Therefore, 36 PwMS who reported depressive symptoms on the depression 
questionnaire did not report being diagnosed with depression by their medical 
professional (see Table 4).  
During the survey, a total of 504 individuals with and without depression 
diagnosis reported as being retired. However, 560 individuals with and without 
depression diagnosis reported having to retire early due to their MS. It must be noted that 
the number of individuals retiring is different because early retirement due to MS 
specifically required participants to answer if they had to leave their job or give up their 
work as a result of health adversities due to MS. However, it may be possible that 
whenever their health adversities were tackled, individuals were able to return to their 
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previous job or started a new job. As such, when participants were asked about their 
current employment status, many individuals reported being retired which may not be 
because of MS. from the analysis it was found that there was a significant difference 
between individuals with and without depression in terms of early retirement due to MS 
(see Table 4).  
 On a side note, from the data that was collected, it was observed that the timeline 
of individuals’ reported diagnosis of depression by their medical professional was 
significantly widespread. The average number of years participants living with a 
depression diagnosis was found to be 17.54, with the maximum being 67 years ago and 
minimum being 1 year ago from the time when the participants completed this survey in 
2012. Out of 191 individuals who reported being diagnosed with depression by their 
medical professional, 132 (69.1%) individuals were able to provide an approximate year 
of their depression diagnosis. 
Research Question 2: What is the prevalence rate of depressive symptoms as 
measured by HADS-D during the survey? Is there a difference between participants with 
and without depressive symptoms on demographic and clinical variables when assessed 
by HADS-D?  
Upon conducting the independent-samples t-test, the Levene’s Test for Equality of 
Variances was statistically significant, for physical disability, and social support. 
Therefore, in order to correct this violation, the t-tests for these comparisons used non-
pooled variances and Welch-Satterthwaite adjusted degrees of freedom (see Table 5). 
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Through the t-test analysis, it was found that participants with and without self-
reported depressive symptoms did not differ on various demographic or clinical variables 
such as total years of education, t(739) = -1.328, p = 0.188, Cohen’s d = -0.097; number 
of years living with MS, t(739) = 0.36, p = 0.72, Cohen’s d = 0.026; and total number of 
physical comorbidities, t(739) = 1.34, p = 0.182, Cohen’s d = 0.098. 
It was noted that individuals with and without depression did differ on a number 
of clinical and demographic variables such as age, t(739) = 3.15, p = 0.002, Cohen’s d = 
0.232, physical disability, t(370.64) = 5.16, p < 0.0001, Cohen’s d = 0.56, and social 
support, t(371.94) = 11.31, p < 0.0001, Cohen’s d = 1.17, and perceived disability, t(739) 
= -12.19, p < 0.0001, Cohen’s d = -0.896. Therefore, participants who are younger in age 
self-reported depressive symptoms more than those who were older; those individuals 
who self-reported depressive symptoms were also noted to have more significant physical 
disabilities that those who did not self-report depressive symptoms. In terms of social 
support, participants who did not self-report depressive symptoms had significantly more 
social support than those who self-reported depressive symptoms. Lastly, those who self-
reported depressive symptoms had significantly greater levels of perceived disability than 
those who did not self-report depressive symptoms on the HADS-D.  
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Table 5: Descriptive Statistics: Demographics, clinical profile and psychological factors 
of self-reported depressed and non-depressed participants (N = 743) 
 
Demographics& 
Clinical Profile 
Total 
Population 
 No Depressive 
Symptoms 
(HADS-D) 
N = 514 
(69.1%) 
Depressive 
Symptoms 
(HADS-D) 
N = 227 
(30.5%) 
 
 Mean (SD) Range Mean (SD) Mean(SD) p 
Age 64.62 (6.18) 55-88 65.08(6.32) 63.54(5.70) ** 
Total years of 
education 
13.47 (2.55) 
5-25 13.55(2.45) 13.29(2.77)  
Number of Years 
living with MS  
24.82 (10.02) 
0-66 24.92(10.24) 24.63(9.54)  
Total number of 
Physical 
Comorbidities 
2.15 (1.87) 0-12 2.08(1.91) 2.01(1.77)  
Social Support 
(PRQ) 
83.45 (16.87) 
16-105 87.96(14.55) 73.08(17.26)  *** 
Physical Disability 
(BI) 
76.17 (24.78) 0-100 79.44(22.84) 68.72(27.39) *** 
Perceived Disability 
(MSIS) 
77.96 (5.64) 29-140 70.96(23.57) 93.69(23.01) *** 
*p< .05. **p< .01. ***p < .001. 
Perceived Disability measured by MSIS- Multiple Sclerosis Impact Scale;  
Physical Disability measured by BI- Barthel Index;  
Social Support measured by PRQ- Personal Resource Questionnaire,  
Depressive Symptoms measured by HADS-D- Hospital Anxiety and Depression Scale 
(Depression) 
 
A chi-square test of independence was calculated comparing self-reported 
depression and various demographic and clinical variables that are categorical in nature. 
A significant interaction was found between gender and depression, x
2
(1) = 6.31, p = 
0.008. A significant interaction was found between early retirement of individuals due to 
MS and depression, x
2
(1) = 12.15, p < .0005, where depressed individuals were more 
likely to take early retirement. A significant interaction was also found between 
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individual’s financial condition and depression, x2(1) = 28.4, p < .0001, where depressed 
individuals were more likely to say that they did not have enough money.  
The percentage of participants that were depressed did not differ in terms of 
RRMS type, x
2
(1) = 1.605, p = .21; or PPMS x
2
(2) = 1.198, p = .27; by living situation, 
x
2
(2) = 0.005, p = 0.99; by antidepressant consumption, x
2
(1) = 0.015, p = .90; MS type, 
x
2
(6) = 5.23, p = .52; and employment status, x
2
(4) = 6.69, p = 0.15 (see Table 4).  
In terms of the odds ratio, it was found that the odds were 1.58 times higher that a 
male individual will report depressive symptoms compared to a female individual. 
Similarly, the odds were 2.02 times higher that a person who had to retire early due to 
his/her MS would be more likely to report depressive symptoms compared to a person 
who did not retire early, and lastly, the odds were 2.6 times higher for a person who 
perceived as not having enough money to report depressive symptoms than a person who 
perceives as having enough money. 
Out of the 743 individuals who participated in the study, 514 (69.1%) did not self-
report depressive symptoms (HADS-D score < 8). Two hundred and twenty-nine 
individuals (30.8%) reported self-identified symptoms of depression (HADS-D score ≥ 8) 
(see Table 6).  
On a final note regarding physical comorbidities, those PwMS who were 
medically diagnosed with depression had a significant association with 
hypercholesterolemia, arthritis, and irritable bowel syndrome. Participants’ self-identified 
depressive symptoms were found to have significant associated with lung disease. Only 
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arthritis was found to have a significant association with depression in older PwMS who 
self-reported depressive symptoms and were medically diagnosed with depression.  
Table 6: Descriptive Statistics: Demographics, Disease Characteristics and Financial 
Characteristics of self-reported depressed and non-depressed PwMS (N= 743) 
Demographics, 
Disease & Financial 
characteristics 
Total Population 
No Depressive 
Symptoms 
N = 514  
(69.1%) 
Depressive 
Symptoms 
N = 227 
(30.5%) 
 
 N % N (%) N (%) p 
Gender      
Male 166 22.4 102 (19.8) 64 (28.2) * 
Female 575 77.6 412 (80.2) 163 (71.8)  
Relapsing-Remitting      
No 356 48 229 (46.5) 117 (51.5)  
Yes 385 52 275 (53.5) 110 (48.5)  
Primary-Progressive      
No  642 88.6 450 (87.5) 192 (84.6)  
Yes 99 13.4 64 (12.5) 35 (15.5)  
Antidepressant        
None 704 95 488 (94.9) 216 (95.2)  
1 or more 37 5 26 (5.1) 11 (4.8)  
Living Situation      
House 715 96.5 496 (96.85) 219 (96.5)  
Assisted Living 
Complex 
16 2.0 11 (2.1) 5 (2.2)  
Long-term care facility 10 1.3 7 (1.4) 3 (1.3)  
Employment Status      
Unemployed 165 22.3 106 (20.6) 59 (26.0)  
Employed (Casual) 24 3.2 19 (3.7) 5 (2.2)  
Employed (part-time) 19 2.6 15 (2.9) 4 (1.8)  
Employed (full-time) 30 4 25 (4.9) 5 (2.2)  
Retired 503 67.9 394 (67.9) 154 (67.8)  
Early retirement due to 
MS 
     
Yes 558 75.4 368 (71.7) 190 (83.7) *** 
No 190 25.6 145 (28.3) 37 (16.3)  
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Current Financial 
Condition 
     
Have money 577  77.9 428 (83.3) 149 (65.6) *** 
Do not have money 164 22.1 86 (16.7) 78 (34.4)  
Province       
NL 48 6.5 35 (6.8) 13 (5.7)  
PEI 6 0.8 5 (1) 1 (0.4)  
NB 14 1.9 12 (2.3) 2 (0.9)  
NS 123 16.6 84 (16.3) 39 (17.2)  
QC 78  10.5 49 (9.5) 28 (12.3)  
ON 105 14.1 70 (13.6) 35 (15.4)  
MB 70 9.4 50 (9.7) 19 (8.4)  
SK 61 8.2 39 (7.6) 22 (9.7)  
AB 80 10.8 54 (10.5) 26 (11.5)  
BC 156 21 114 (22.2) 42 (18.5)  
YK 2 0.3 2 (0.4) 0 (0)  
*p< .05. **p< .01. ***p < .001. 
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Table 7: Pearson’s Correlation Analysis of Study Variables to Explore the Significant Association with Self-Reported 
Depressive Symptoms and Medically Diagnosed Depression in Older PwMS. 
 
Variables 1 2 3 4 5 6 7 8 9 10 11 
1. Gender -           
2. Age .069 -          
3. Early retirement due to MS .041 -.128
**
 -         
4. Financial condition .007 .107
**
 -.162
**
 -        
5. Number of years living with MS .015 .263
**
 .061 .051 -       
6. Number of physical comorbidities -.076
*
 .292
**
 .005 -.055 .077
*
 -      
7. Perceived disability .050 -.012 .330
**
 -.299
**
 .048 .062 -     
8.Physical disability -.035 -.089
*
 -.221
**
 .142
**
 -.202
**
 .031 -.573
**
 -    
9. Social support -.046 .117
**
 -.089
*
 .218
**
 -.001 .009 -.236
**
 .088
*
 -   
10. Self-reported depressive symptoms .092
*
 -.115
**
 .128
**
 -.196
**
 -.013 -.049 .409
**
 -.199
**
 -.406
**
 -  
11. Medically diagnosed depression .046 -.051 .052 -.108** .032 .082* .264** -.130** -.239** .549** - 
Note. 
*. Correlation is significant at the 0.05 level (2-tailed). 
**. Correlation is significant at the 0.01 level (2-tailed). 
***. Correlation is significant at the 0.001 level (2-tailed). 
MSIS- Multiple Sclerosis Impact Scale; BI- Barthel Index; PRQ- Personal Resource Questionnaire 
HADS-D- Hospital Anxiety and Depression Scale (Depression) 
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4.3 Predictors of Depression 
Research question 3: What are the independent predictors of depression in older PwMS?  
 The goal of this research question was to explore which demographic and clinical 
variables independently predicted depression in older PwMS after taking into account the 
other variables. To have a more parsimonious model, the predictors included only those 
variables that had a significant relationship with either medically diagnosed depression or 
self-identified depressive symptoms. Table 7 lists these predictors and provides the 
intercorrelations between these predictors. As can be seen from this table, the 
intercorrelations are not excessively high, so there are no concerns of multicollinearity. 
Age, gender, early retirement due to MS, current financial condition, physical 
comorbidities, perceived disability, physical disability, and social support are the seven 
predicting variables. A conservative method was used to construct the dependent variable 
(presence and absence of depression) for the final predictive model. Depressed 
participants are classified as those who self-reported depressive symptoms on HADS-D 
and reported being diagnosed with depression by their medical professional. Non-
depressed participants on the other hand, are classified as those who either had medically 
diagnosed depression but had a score lower than the cut-off on the HADS-D, or vice 
versa, or neither (i.e., lower than cut-off on HADS-D or no depression diagnosis by a 
medical professional). 
The results from the previous two research questions demonstrated that each way 
of defining depression leads to different patterns of results, which offers support to the 
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finding that it is difficult to diagnose depression in people with MS (Gunzler et al., 2015; 
Tylee & Gandhi, 2005; Feinstein et al., 2014). One hundred and four people were 
diagnosed with depression but did not meet the HADS-D cut-off score and 140 people 
scored above the HADS-D cut-off but were not diagnosed with depression. They were 
classified as non-depressed participants along with those who did not self-report 
depressive symptoms and reported not receiving a depression diagnosis. For the final 
analysis, it was found that 656 (88.3%) participants were ‘Non-depressed’ and 87 
(11.7%) participants were ‘Depressed.’  
The Omnibus Tests of Model Coefficients table indicated that the inclusion of the 
predictive variables contributed significantly to model fit. The p value was less than .05 
(p < .0001) which meant that there was some predictive capacity in the regression 
equation and that the block 1 model was a significant improvement to the block 0 model.  
The analysis revealed that the significant predictors which had a unique 
contribution in predicting depression were social support, perceived disability, and 
physical comorbidity when all other independent variables were controlled. It was found 
that the odds of having depression were greater for people with less social support. For 
every 1 unit decrease in the score on the social support measure (i.e., PRQ), the odds of a 
participant being depressed increased by a factor of 0.97 (Odds Ratio [OR] = .97; 95% CI 
[0.96, 0.98]; p < .0001). In other words, with every unit decrease in the score on PRQ, the 
odds of a participant having depression increased by 3.2%. The odds of having depression 
were greater for participants with higher levels of perceived disability. For every 1 unit 
increase in the score on the perceived disability measure (i.e., MSIS), the odds of a 
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participant being depressed increased by a factor of 1.03 (OR = 1.03; 95% CI [1.02, 
1.05]; p < .0001). In other words, with an additional increase in the score on MSIS, the 
odds of a participant having depression increased by 3.34%. The odds of having 
depression was greater for people with increasing number of comorbid physical 
conditions (OR = 1.17; 95% CI [1.03, 1.33]; p = .015). It was found that for an additional 
comorbid physical condition, the odds of having depression increased by 17.2%.  
From the multivariate analysis it was found that age, gender, early retirement due 
to MS, current financial condition, and physical disability were not significant predictors 
of depression in older PwMS (see Table 8). However, when medically diagnosed 
depression and self-identified depressive scores were considered separately, the above 
variables were shown to have a significant association with either or both forms of 
depression. 
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Table 8: Summary of Multiple Logistic Regression Analysis of the Significant Variables to  
Determine the Predictors Depression in Older PwMS.  
Note:e
B
 = exponentiated B(Odds Ratio). Independent Variables (gender, age, current 
financial condition, early retirement due to MS, total physical comorbidity, perceived 
disability, physical disability, and support).  
*p< .05. **p< .01. ***p < .001. 
Perceived Disability measured by MSIS- Multiple Sclerosis Impact Scale;  
Physical Disability measured by BI- Barthel Index;  
Social Support measured by PRQ- Personal Resource Questionnaire,  
Depressive Symptoms measured by HADS-D- Hospital Anxiety and Depression Scale 
(Depression) 
 
 
Predictors of Depression 
Predictors B 
e
B
 (Odds 
Ratio) 
95% C.I. p 
Age -0.033 0.968 [0.93, 1.01] .143 
Gender 0.368 1.445 [0.83, 2.51] .191 
Early Retirement due 
to MS 
-0.375 0.687 [0.36, 1.31] .257 
Current Financial 
Condition 
0.060 1.061 [0.61, 1.84] .831 
Physical 
Comorbidities 
0.159 1.172 [1.03, 1.33] .015* 
Perceived Disability 0.033 1.034 [1.02, 1.05] <.0001*** 
Physical Disability 0.001 1.001 [0.99, 1.01] .709 
Social Support -0.032 0.968 [0.96, .98] <.0001*** 
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  Chapter 5 
Discussion 
5.1 Findings 
This chapter is divided into six sections. In the first part, there will be an overall 
review of the prevalence of depression in older PwMS that formed the cohort. Several 
studies have demonstrated the difficulty in isolating depressive symptoms from MS-
related symptoms due to the frequently occurring overlap in MS and depression (e.g., 
sleep difficulties, appetite, fatigue, cognitive functioning) (Gunzler et al., 2015; Tylee & 
Gandhi, 2005). As such, this study attempted to explore if there is a difference in 
depressed and non-depressed participants on two aspects (i.e., when participants reported 
receiving a diagnosis of depression by their medical professional and when participants 
self-reported depressive symptoms as assessed by HADS-D) in terms of demographic and 
clinical variables. In order to find the independent predictors of depression in PwMS, this 
study employed a more stringent method of selection criteria (i.e., depressed and non-
depressed). Individuals who reported receiving a diagnosis of depression from a medical 
professional, as well as self-identified depressive symptoms formed the part of the 
depressed group. Following the review of the prevalence of depression in PwMS, each 
research question will be presented with their results, and they will be discussed with 
references from the literature. Reasons behind possible variations from the literature 
compared to this present study, will also be addressed. Next, the general implications of 
this study will be offered. The need for continuous monitoring of depressive symptoms 
and the role of multidisciplinary teams to provide holistic care to older PwMS will be 
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discussed as a possible way to tackle depression in this population. The strengths and 
challenges of this study will be presented, followed by suggestions for future research. 
Finally, a general conclusion will be presented at the end of this chapter.  
5.1a. Prevalence of Depression 
This study supports the claim that depression is a common psychological disorder 
in older PwMS, as was shown by previous research (Feinstein & Feinstein, 2001; Katon, 
2011; Mrabet et al., 2014; Patten et al., 2000). In our study, the life time prevalence rate 
of depression when participants reported being diagnosed by their medical professional is 
25.7%. The prevalence rate of depression when participants self-reported depressive 
symptoms during the time of the survey through a depression questionnaire (HADS-D) 
30.5%. Both these rates of depression are very close to each other as well as a robust 
systematic review of 118 research studies, that reported the prevalence rate of depression 
in PwMS to be approximately 23.7% (95% CI: 17.4%-30.0%) (Marrie, Reingold, et al., 
2015). Patten, Beck, Williams, Barbui, & Metz (2003) conducted a study using data from 
the CCHS and did brief interviews on PwMS (age 18 to 45years). Patten and colleagues 
reported a 25.7% prevalence rate of major depression in their population which is also 
similar to the prevalence rate of our study among the participants who reported receiving 
a depression diagnosis by their medical professional (i.e., 25.7%). Those research studies 
that used a cut-off score on a self-report measure to assess depression (e.g., Beck 
Depression Inventory, HADS-D, Centre for Epidemiologic Studies Depression Scale, 
Depression Self-Rating Scale, Patient Health Questionnaire, etc.), reported a prevalence 
rate of depression that ranged between 11.6% to 41.8% (Beal et al., 2007; Chwastiak et 
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al., 2002; Singer et al., 2009; Viner et al., 2014). This range is also within the prevalence 
rate of HADS-D assessed depressive symptoms in our study (i.e., 30.5%).  
There was a significant correlation between self-reported depressive symptoms 
and medically diagnosed depression. Odds were higher for those individuals who 
received a diagnosis of depression from their medical professional to also score above the 
cut-off score on the self-reported measure (HADS-D) of depression. This is an important 
finding in this study because the number of years before individuals received a diagnosis 
of depression by their medical professional varied (i.e., from 1 year to 67 years with a 
mean of 17.54 years), and researchers were unable to determine if participants’ 
depression remitted during the time of the survey. However, the odds were 2.45 times 
higher for those individuals who received a depression diagnosis to also report depressive 
symptoms on the HADS-D during the time of the survey. This may be due to two 
reasons: first, PwMS continued to have depressive symptoms that did not remit from the 
time they were first diagnosed. Second, self-identified depressive symptoms as measured 
by the HADS-D may, in fact, reflect symptoms of MS rather than depression (e.g., items 
such as “I feel as if I am slowed down”). It has been shown in the literature, that one of 
the main concerns among healthcare professionals is the difficulty of separating MS 
symptoms from depressive symptoms due to significant overlap of psychological and 
neurological symptoms of the two diseases (Gunzler et al., 2015; Tylee & Gandhi, 2005). 
Therefore, in order to prevent the misidentification of depressive symptoms as MS 
symptoms, or vice versa, a stringent method is used in this present study to allocate 
participants in depressed and non-depressed groups. Only those PwMS who received a 
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depression diagnosis by their medical professional and who also self-identified depressive 
symptoms when assessed by HADS-D were considered depressed individuals in this 
study. From the sample population, 87 (11.7%) participants reported receiving a medical 
diagnosis of depression, as well as self-identified depressive symptoms during the time of 
this survey.  
In our study, 104 out of 191 PwMS who received a depression diagnosis prior to 
the survey did not self-report depressive symptoms during the time of the survey. This 
difference in the number of people reporting symptoms is because their symptoms may 
have remitted from the time they were medically diagnosed to when the survey was 
conducted. Therefore, if we had used only medically diagnosed depressed participants as 
a sufficient criterion to compare with non-depressed participants, the results of the 
analyses may not have been an accurate representation of the association of depression 
with demographic and clinical variables. For example, the direction on the MSIS-29 
states, “the following questions ask for your views about the impact of MS on your day-
to-day life during the past two weeks.” Whereas, the item on the survey that asked 
participants if they had a depression diagnosis, did not ask them if they had depression 
during the time of the survey which may have explained the association of depression 
with perceived difficulty. Only the HADS-D could assess if participants had depressive 
symptoms during the time of the survey as according to the direction, participants are 
asked to, “tick the box beside the reply that is closest to how you have been feeling in the 
past week.” However, a confirmed diagnosis of depression was not possible through 
HADS-D due to the above-mentioned issues related to symptom overlap with MS. 
Therefore, considering either medically diagnosed depression or HADS-D alone to find 
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predictors of depression was thought to be an inadequate approach when identifying 
participants as depressed or non-depressed in this study.  
This study revealed that older adults with MS, whether they have self-identified 
depressive symptoms, a depression diagnosis by a medical professional, or both, had 
significantly lower levels of social support, and higher levels of perceived disability 
compared to those who did not have depression. Mid to high-level relationships were 
reported in this study between physical comorbidities and medically diagnosed 
depression, with a higher number of physical comorbidities showing a greater association 
with depression. Higher levels of perceived disability associated with depression in 
PwMS. Lower levels of social support were associated with depression. This is an 
important finding in this study because the literature showed that the presence of one or 
more physical comorbidities, low levels of social support, and high levels of perceived 
disability were significantly associated with depression (Aghaei et al., 2016; Costa et al., 
2012; Marrie et al., 2008; Marrie & Horwitz, 2010; Mohr et al., 2004; Smith & Young, 
2000).  
When compared based on gender, men were found to self-identify depressive 
symptoms and were diagnosed with depression more than women. This is a significant 
addition to the MS literature because this result is contrary to the findings from most 
studies of the general population as well as the primary care population, including PwMS 
(Di Marco et al., 2006; Kessler, 2006; Magyari et al., 2014; Piccinelli & Wilkinson, 
2000). One of the possible reasons behind such result may be that physicians are focusing 
more on asking questions related to depressive symptoms to male individuals because 
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physicians are aware of high suicide rate in males and understand that men may be more 
vulnerable to depression. Although according to Vafaei, et al., (2016), gender roles have 
been an important determinant in expression and experiencing of depressive symptoms, it 
cannot be assumed for certain that those male individuals who do not conform to 
masculine social roles were less depressed than those who did. It may also be possible 
that men are becoming more aware and comfortable sharing their emotional state with 
their medical professional and enhancing help seeking behaviours which led to more 
diagnosis of depression. Adaptive help seeking behaviours for depression among men are 
discussed by researchers Addis, and Mahalik, (2003).  
PwMS who had to retire early due to their MS, compared to those who did not, 
were also found to have both a medical diagnosis of depression as well as self-reported 
depressive symptoms. This finding supports various research studies that also showed that 
early retirement is associated with depression in individuals from the general population 
and those with MS (Karpansalo et al., 2005; Orlewska et al., 2005; Rice et al., 2011; Shih 
et al., 2016).  
There were some variances found in terms of self-identified depressive symptoms 
and medically diagnosed depression. Older adults who self-identified depressive 
symptoms also had significantly higher levels of physical disability, while medically 
diagnosed depression was not significantly associated with physical disability. This may 
be because some symptoms (e.g., fatigue, low energy) of physical disability are a result of 
MS and may not be due to depression, even though MS and depression share those same 
symptoms. Another potential explanation may be that some items of BI measured the 
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perceived difficulty of the participants. This is because the participants completed the 
questionnaire themselves instead of their health care provider. It may be that individuals’ 
view on their own self-reported physical limitations of their performance was associated 
with self-reported depressive symptoms. Whereas, when PwMS were objectively 
assessed by a medical professional for depression, self-reported physical disability was 
found to have no significant association with depression. If we assume that the self-
reported depressive symptoms are a representation of MS and not depression, which is 
why physical disability was not associated with self-reported depression symptoms, then, 
this mismatch may also be due to a mechanism called response shift. According to 
Schwartz, and Sprangers, (2009), response shift alludes to the change in the meaning of 
one’s self-evaluation of a construct by changing in their internal standards of 
measurement, by changing their values and priorities, or changing their definition of the 
construct. For example, a person with who believed running a 10K was their definition of 
“being fit,” may change their definition after being diagnosed with MS or living with MS 
for 20 years. This recalibration and redefinition may be the reason why medically 
diagnosed depressed and non-depressed participants did not differ on physical disability 
physical disability as their definition of physical disability changed.  
In terms of age, younger PwMS were more depressed according to the self-report 
questionnaire (i.e., HADS-D). Results show that advancing age is not significantly 
associated with depression, and in fact it is the opposite. The age group of our cohort is 
quite varied (i.e., 55 years and over) and it is understood that a 55-year-old with MS may 
not have similar reasons for their depressive symptoms compared to a much older (e.g., 
PREDICTORS OF DEPRESSION IN MS 
91 
 
65 to 70 years) person with MS. However, the significant association between depressive 
symptoms and age in older PwMS supports the broader conclusions of other studies from 
the literature on the general older population as well as in PwMS that age is associated 
with impacts mood (Leach et al., 2008; Rodda et al., 2011; Seyed Saadat et al., 2014). 
Our result on younger adults in the older population being more are affected by mood or 
that advancing age does not necessarily impact mood is also supported by others in MS 
population (Patten, Metz, & Reimer, 2000). As Kneebone et al., (2003) reported in his 
research study that older adults (age 65 years and older) in fact seemed to be less 
vulnerable to depression may be because they are less emotionally responsive. It also 
supports the view of Ploughman et al., (2012) that older adults learned to live and cope 
with MS for many years and hence the MS related changes do not impact their mood. 
Irrespective of these associations, various aspects of depressive symptoms can fluctuate 
over time. A three-year longitudinal study by Arnett and Randolph (2006) revealed that 
symptoms such as sadness and irritability fluctuated more than symptoms such as 
worthlessness, inappropriate guilt, sleep, and appetite. Therefore, several factors may 
have played a role in low mood, whereby age had a significant association with self-
reported depressive symptoms during the time of the survey, whereas, age did not have 
any association with medically diagnosed depression. Also, it must be noted that although 
older age was related to greater self-reported depressive symptoms, length of MS or 
disease duration was not. This finding is consistent with Beal et al. (2007), who found 
that the length of MS did not influence self-reported depression over a period of 7 years. 
This finding was also in accord with Arnett and Randolph (2006), who demonstrated that 
symptoms of depression were quite stable over time.  
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In terms of financial condition, the literature shows that there is an association 
between low financial status and depression in the general population as well as 
specifically in PwMS (Butterworth et al., 2009; Green et al., 2007; Kobelt et al., 2006; 
Mirowsky & Ross, 1999; Orlewska et al., 2005; Wang et al., 2010). In support of the 
current literature, findings from this study revealed that people who reported not having 
enough money were more likely to report depressive symptoms on the HADS-D 
questionnaire than those who noted having enough money. This finding is similar to 
Marrie et al. (2009) who reported that lower levels of income were associated with an 
increased risk of depression. There were no significant association noted between low 
financial levels and medically diagnosed depression in this population.  
As for the relationship between the type of MS and depression, even though we 
dichotomized progressive versus non-progressive MS like Beal et al. (2007), we did not 
find that progressive forms of MS were related to having depression as Beal and 
colleagues did. However, the literature on rates of depression in people with RRMS and 
progressive MS provides mixed results (Feinstein et al., 2014).  
There were some variations noted in terms of self-reported depressive symptoms 
and depression diagnosed by a medical professional. There were more PwMS who self-
reported depressive symptoms during the time of the survey than persons who were 
medically diagnosed with depression. This may be due to two possible reasons. First, the 
self-reported symptoms of depression identified by PwMS through the HADS-D 
questionnaire may be symptoms of MS and not depression which may be due to the 
overlap of somatic symptoms found in MS and depression. A similar view was shared by 
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Feinstein et al. (2014) who acknowledged the challenges faced by researchers and 
clinicians when defining and diagnosing depression in the context of MS noting that there 
are major overlaps in psychiatric and neurological symptoms. The second reason may be 
due to the under-diagnosis of depression in general and primary care population. While 
227 PwMS meet criteria for depression according to the self-report measure (i.e., HADS-
D), 191 people had a confirmed diagnosis. Therefore, depression was not diagnosed in 36 
people who self-reported depressive symptoms. This finding is also supported by Marrie 
et al. (2009) who found that potentially undiagnosed depression was frequent in PwMS. 
Their research showed that 15% of PwMS who did not report depression as a mental 
comorbidity, had scored above the cut-off (≥ 21) on the Center for Epidemiologic Studies 
Depression Scale (CES-D) indicating probable major depression. As such, they concluded 
that depression frequently remains undiagnosed in PwMS. Regardless of whether 
depression was self-identified or diagnosed by a medical professional, exploring possible 
predictors of depression is thought to help clinicians to routinely assess for mood 
disorders in at-risk PwMS which in the long run may prevent depression.  
5.1b. Predictors of Depression 
 As discussed above, due to the frequent overlap of the psychiatric and 
neurological symptoms of MS with those of depression, a more stringent method was 
employed to define depression in order to minimize false positive cases. In this section, 
depression is denoted by both the presence of self-reported depressive symptoms 
according to the cut-off score (≥8) on HADS-D and a diagnosis of depression as provided 
by the participant’s medical professional.  
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Physical Comorbidities 
The variable “total number of physical comorbidities” was the strongest 
independent predictor of depression among older PwMS according to this study. 
According to the study conducted by Marrie et al. (2008), out of 8,953 PwMS, 3,280 
(36.7%) accurately self-reported comorbid conditions, and the three most common 
conditions reported were hypercholesterolemia (37%), hypertension (30%), and arthritis 
(16%). Another research study that investigated the effect of comorbidities in HRQoL in 
949 PwMS (mean age 48.62 years) found hypertension (17.8%) and hypercholesterolemia 
(12.4%) to be the most common types of comorbid physical conditions (Berrigan et al., 
2016). In our study, out of 743 PwMS, 633 (85.2%) participants reported having at least 
one comorbid condition and the most common type of condition reported was 
hypertension (35.7%), followed by hypercholesterolemia (26.6%) and arthritis (24.5%). 
Therefore, our study also supports the claim that PwMS are most commonly diagnosed 
with hypertension, hypercholesterolemia, and/or arthritis. Various research studies have 
shown that having a chronic condition makes a person vulnerable to depression (Becofsky 
et al., 2013; Hughes et al., 2014). Through a systematic review of over 249 studies by 
Cohen et al. (2015) it was demonstrated that there is an increase in the prevalence of 
comorbid conditions in PwMS. As demonstrated by the research conducted by Marrie et 
al., (2009), our study supports that the interaction of a comorbid disease and depression 
may pose challenges in the diagnostic process and the management of depression, as well 
as worsens MS-related symptoms. Similar to the findings from the literature regarding 
various chronic conditions and their impact on mood, results from our study suggest that 
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psychical comorbidities (e.g., arthritis, hypertension, and hypercholesterolemia) are risk-
factors for depression in older PwMS.    
Social Support 
Consistent with most of the MS and social support literature, our study found that 
greater perceived social support was associated with less depression above and beyond 
the variance accounted for by demographic and disease-related variables. This result is 
similar to the studies that were conducted with the general population, the primary care 
population, and specifically with PwMS across all ages as well as older adults (Bambara 
et al., 2011; Benmarhnia & Zunzunegui, 2014; Faramarzi et al., 2015; Grav et al., 2012; 
Hughes et al., 2014; Wu et al., 2013). Findings from our study are consistent with various 
studies conducted across the world suggesting that, irrespective of available resources, 
lack of social support remains one of the primary risk-factors of depression (Faramarzi et 
al., 2015; Fauth, Gerstorf, Ram, & Malmberg, 2012; Feinstein, 2011; Siegert & 
Abernethy, 2005). Evidence from this study confirms that social support is beneficial and 
is needed to reduce the risk of developing depression in older PwMS. The stress-buffering 
hypothesis, proposed by physician and epidemiologist John Cassel and psychiatrist 
Sidney Cobb in 1976 suggests that individuals who have more social support are better 
protected from the negative consequences of stressors such as illness, life-events, and 
developmental transitions (Cassel, 1976; Cobb, 1976). Social support also helps 
individuals to be active and have a less sedentary lifestyle. For example, having 
commitments to attend a function, a social or religious ceremony, or going out for a group 
stroll down to the park urge individuals to engage in physical activities. As such, social 
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support may inform positive health behaviours in older PwMS. Social participation like 
attending a community yoga class or a meet-up group may promote healthy living and 
increase feelings of belonging, which may also be a protective factor against depression 
(Chronister, Johnson, & Berven, 2006; Grossman et al., 2010; Turner & McLaren, 2011). 
The view that depression negatively impacts social participation is also supported by 
Beekman et al. (2002) who conducted a prospective community-based study on older 
PwMS (55 - 85 years) in the Netherlands. Therefore, we can determine that low social 
support is a significant risk factor for depression in older PwMS.  
Perceived Disability 
Perceived disability is a significant predictor of depression in our cohort. 
Literature on perceived disability suggests that depression impacts one’s self-efficacy 
which is a determining factor in the development of disability in the primary care 
population (e.g., chronic pain, arthritis) (Arnstein et al., 1999; Menendez et al., 2015; 
Nabolsi et al., 2015; Roh et al., 2012; Shnek et al., 1997). In individuals with 
fibromyalgia, chronic fatigue syndrome, and arthritis, research showed the positive 
impact of treating depression on one’s perception of pain and/or functional limitations 
(Becofsky et al., 2013; Menendez et al., 2015; Wolfe & Michaud, 2009). Therefore, 
PwMS who share similar symptoms as with people with arthritis may also have similar 
benefits from the treatment for depression. In PwMS, Smith and Young (2000) showed 
similar results wherein depressed PwMS using BDI and HADS criteria were three times 
more likely than non-depressed PwMS to perceive their disability as being greater than 
their physician’s assessment of their disability. Our result, on the other hand, makes a 
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unique and important contribution to the literature because it shows that PwMS who 
perceive themselves as disabled are at a greater risk of having depression. Our finding 
that perceived disability is a predictor of depression supports Beck’s Cognitive Theory of 
Depression by Allen (2003), which states that depression is a result of one’s view of 
oneself, rather than one’s negative view of oneself being the result of depression.  
Low social support, higher levels of perceived disability, and physical 
comorbidities are risk factors for depression in older PwMS. Therefore, those individuals 
who have been living with MS for over two decades and have learned coping strategies to 
deal with their disease may still develop depression if they are at risk due to one or more 
of the above factors. As such, those older PwMS who report a lack of social support, have 
one or more secondary chronic condition/s along with MS, and/or have a high perceived 
level of disability should be regularly screened for depression through a self-report 
measure as well as structured and/or semi-structured interviews.  
5.2 Strength of the study 
One of the main strengths of this study is its large sample size that adequately 
represents the national population of older people with MS in Canada. Participants were 
recruited from eight different provinces across Canada which also speaks to the 
geographical generalizability. 921 PwMS were initially contacted, of whom 743 (81%) 
participants completed and returned the questionnaire. This is a relatively strong 
indication of older peoples’ desire to find answers to their difficulties due to MS. It also 
reflects the need to provide older PwMS with new information as they are equally keen 
on learning about their disease even though they have lived with it for over 20 years. 
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Participants were from various socioeconomic categories, educational levels, financial 
backgrounds, and levels of disability. The first two analyses in this research study used 
the large population and had a robust representation of depressed and non-depressed 
participants.  
This study used reliable and valid instruments to assess depression, social support, 
and perceived disability. In terms of measuring depression, research shows that HADS is 
a popular instrument used in people with primary health care issues (Al-Gamal, 2015; 
Honarmand & Feinstein, 2009; Singer et al., 2009). There is a high overlap of the somatic 
symptoms of depression with that of MS. Therefore, various research studies prefer using 
HADS over other tools like the Beck Depression Inventory (BDI) to measure depression 
as the items of HADS are not heavily based on somatic symptoms (e.g., pain, fatigue, 
appetite, sleep) (Feinstein et al., 2014; Tylee & Gandhi, 2005). As such, participants’ 
responses on HADS can be assumed to be a relatively accurate representation of their 
actual mood as HADS produces minimal false positive cases. This was primarily 
supported by a meta-analysis (i.e., 50 studies) that demonstrated the diagnostic validity of 
the HADS in cancer and palliative settings (Mitchell, Meader, & Symonds, 2010). 
Various researchers described the difficulties in differentiating depressive symptoms from 
clinical symptoms of MS due to the psychiatric and neurological overlap between the two 
diseases. As such, this study used a more stringent method to be able to accurately 
determine depression and avoid false positive cases due to symptom overlap (Feinstein et 
al., 2014; Gunzler et al., 2015). The depressed cohort had a diagnosis of depression 
provided by their medical professional and their self-report scores on the depression 
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measure were above the cut-off score (HADS-D ≥8). The initial analyses were conducted 
on individuals with self-reported depression and medically diagnosed depression 
separately. This was done to examine the significant association of, a., medically 
diagnosed depression with demographic and clinical variables, and b., self-reported 
depressive symptoms with demographic and clinical variables. The final analysis to 
examine the predictors of depression was done with individuals who had both self-
reported depressive symptoms as well as medically diagnosed depression.  
This study is the first national survey that investigated two aspects of disability 
(i.e., physical disability and perceived disability) to explore which of the two types of 
disability is a risk factor for depression in older PwMS. While physical disability is 
measured by limitations in functional activities, perceived disability takes into 
consideration an individuals’ insight of their limitations posed by MS.  
Most research studies focus on individuals that have been recently diagnosed with 
MS and who are generally much younger than 55 years. This study provides insight into 
the factors that interfere with healthy aging in older PwMS by recognizing the risk-factors 
for depression in this population. Depression may complicate MS symptoms. As such, 
understanding and knowing the risk-factors will not only prevent depression but also help 
manage MS-related symptoms. Over the years, participants of this study may have 
acquired self-tested strategies that enabled them to live with an unpredictable chronic 
disease for more than 20 years. At the same time, these participants also face unique 
challenges due to their advancing age that may be different from those faced by the 
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younger population. Therefore, exploring the factors associated with depression in older 
PwMS is an essential aspect in promoting healthy aging.  
Frequently, researchers faced difficulties recruiting a large sample size, but in our 
study, the use of postal service to send out the questionnaires, and pre-paid reply 
envelopes were some helpful strategies that resulted in uniform recruiting of a 
representative sample. 
5.3 Limitation of the study 
The main limitation of the study is the cross-sectional design that prevents us from 
forming causal relationships between variables. The sample size was not evenly 
distributed across depression. Non-depressed participants represented three times that of 
depressed participants in our sample population. This may be due to lack of motivation 
(amotivation) in depressed participants to self-identify in order to be recruited as a 
potential research participant. Amotivation and lack of interest are symptoms of 
depression that are often seen as a barrier to research participation. In a systematic 
review, researchers found 15 studies that stated that the decision to participate in a 
research study depends on patient’s health at the time when they are requested to 
participate (Hughes-Morley, Young, Waheed, Small, & Bower, 2015).  Therefore, health 
concerns of participants may have been a challenge in this primary care population during 
recruitment.  
Another significant challenge that is especially faced by researchers who mail 
their research measures is the inability to control the testing situation. Although the 
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questionnaire set contained instructions on how to complete the questionnaire (e.g., taking 
rest between chapters), participants may have used their own discretion on how they 
completed the questionnaire package (Ploughman et al., 2012). This may be influenced 
by participant’s fatigue, pain, mood, or external factors. Also, discussing responses with 
another family member may skew the data and may not reflect participants’ own 
reactions as well.  
One of the major limitations of self-report questionnaires is that there is no way to 
determine whether respondents give honest answers to questions. The resistance to report 
accurately on mental health questions may also be a major limitation of self-report 
questionnaires and participants may show social desirability bias (Grimm, 2010).  
Canada is a multi-cultural nation. Therefore, the research population may have 
had a large distribution of different ethnicities. Culture and race may play a significant 
role in interpreting psychopathology. This may create reference bias, which occurs when 
questionnaires are influenced by differing standards of comparison. A person deciding 
whether he or she is depressed must envision a mental image of a depressed person which 
he or she can compare with. For example, a meta-analysis was conducted to examine the 
racial/ethnic differences in the factor structure of the Center for Epidemiologic Studies 
Depression Scale (CES-D) to screen for depression. Results from the analysis cautioned 
clinicians and researchers when using the CES-D to screen for depression because 
symptoms of depression may be presented differently by different racial/ethnic groups 
(Kim, DeCoster, Huang, & Chiriboga, 2011).  
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Items of HADS are based on a Likert scale. As such, the responses are subjective 
and depend on the participant’s ability to conceptualize each item that corresponds to 
their symptoms of depression. Although rating scales allow participants to provide more 
nuanced responses than a simple “yes-no,” using rating scales may also be problematic. 
Participants may interpret and use scales differently. For example, one person may rate 8 
on a 10-point scale, and with the same opinion, someone else may rate 6/10 because they 
interpret the meanings attached to the scales differently (Austin, Deary, Gibson, 
McGregor, & Dent, 1998).  
According to Bocerean and Dupret (2014), symptoms of depression and anxiety 
often overlap. Therefore, the scores on the HADS-D component may not reflect the true 
depression score of participants. Also, the authors noted that HADS-D measures only the 
anhedonic symptoms (i.e., symptoms that reflect despondency and inability to engage in 
activities that they did before) of depression. Therefore, people who exhibit more somatic 
or cognitive symptoms (e.g., fatigue, low energy, change in appetite or sleep, and 
concentration and memory problems) may not score high on HADS-D. As such, the 
somatic symptoms that an individual may verbalize to their physician may be interpreted 
as symptom of MS and not depression. In a systematic examination of the diagnostic 
performance of HADS and BDI in a sample of 298 French participants, Sultan, Luminet, 
and Hartemann (2010) reported that the depression subscale of the HADS performed 
poorly. They also noted that according to their result, along with depressed mood, both 
negative thoughts and anxiety are important symptoms that clinicians need to consider for 
the correct identification of clinical depression in chronic illnesses. As such, Sultan et al. 
PREDICTORS OF DEPRESSION IN MS 
103 
 
(2010) recommended using the total score when using the HADS. While some studies 
supported the used of HADS-D, others recommended using the complete HADS to screen 
for depression. In order to deal with this uncertainty, our research study only considered 
those participants whose score on HADS-D was above the cut-off and who had a 
depression diagnosis from a medical professional.  
There was no way to confirm if the diagnosis of depression provided by the 
medical professional was given after conducting a brief interview with the participants to 
confirm depression. It was also a form of participants reported depression diagnosis that 
they noted were given by medical professional. In terms of gender, a limitation is that 
there may have been some confounding factors involved when defining gender and sex of 
the participants.  
Lastly, while the Barthel Index measures functional limitations by observing 
performance, the directions on the assessment instructs participants to “choose the scoring 
point for the statement that most closely corresponds to the patient’s current level of 
ability for each of the following 10 items. Record actual, not potential, functioning.” 
However, our survey does not clarify this aspect. As such, depending on the participant’s 
understanding, items on the Barthel Index may still be answered as perceived difficulties 
as they are completed by PwMS and not by their physician.  
5.4 Clinical Implications 
Given the statistically significant findings of this study, it is important to consider 
their implications. Depression is an important factor that needs to be monitored on a 
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regular basis by an individual’s health care provider. PwMS may not report symptoms 
that are exclusive to depression like those that emulate symptoms of MS (e.g. fatigue, 
cognitive difficulties, and pain), and they may continue living with the symptoms. This 
can worsen MS, as well as complicate the aging process. The study found that social 
support, perceived disability, and physical comorbidities were strong independent 
predictors of depression in older PwMS. As such, if a person with MS reports low social 
support, high perceived disability and/or has one or more physical comorbidities (e.g., 
hypertension, hypercholesterolemia, arthritis), then he/she is at risk of depression. 
Therefore, during an intake session, or a regular medical visit, if a person reports one or 
more above-mentioned variables as a potential concern, then his/her health care provider 
must screen for depression with a structured and/or semi-structured interview and a 
screening tool. Therefore, this research is of great clinical importance as it reflects, and 
substantiates, the need for regular assessment of depression in older PwMS.  
This study acknowledges the difficulty in differentiating depressive symptoms 
from that of MS symptoms due to the neurological and psychological symptom overlap 
between the two diseases. It shows that self-reported depressive symptoms are strongly 
associated with physical disability, while medically diagnosed depression is significantly 
associated with physical comorbidities. Due to the difference in the variables and their 
association with self-reported versus medically diagnosed depression, medical 
professionals are encouraged to use clinical interviews and/or clinical impressions as well 
as screening tools when diagnosing depression in PwMS.  
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Timely treatment of depression in older adults with MS can be an effective way to 
tackle economic burdens related to depression and the management of MS symptoms. For 
example, perceived disability (i.e., the perception of disability caused by MS) is 
associated with depression (Smith & young 2000). Therefore, providing therapy (e.g., 
Cognitive Behaviour Therapy) to challenge one’s perception and unhelpful ways of 
thinking can be helpful in managing and preventing depression in PwMS (Clancy, 
Drerup, & Sullivan, 2015). Policy makers, particularly those of programs in community 
and hospitals, neurologists, and psychologists, as well as allied healthcare professionals, 
could benefit from being made aware of these associations and risk-factors of depression. 
Depression is alarmingly common among primary care settings, which makes it 
difficult for PwMS to receive treatment for mood disorders from specialized professionals 
such as clinical psychologists. There is a significant need for an interdisciplinary team in 
primary care settings not only to provide holistic care to patients but also to promote 
health care cost effectiveness and time effectiveness. A collaborative care approach for 
depression for PwMS using primary care facilities will be beneficial. According to Gunn 
et al. (2006), collaborative care is a comprehensive intervention strategy that includes an 
interprofessional approach to patient care. It consists of a structured disease management 
plan, scheduled patient follow-ups, and increased interprofessional interactions within the 
same primary care setting.  
It must be emphasized that due to the non-experimental nature of this study, 
causal links between self-reported depressive symptoms, or medically diagnosed 
depression and demographic and clinical variables cannot be established. As such, 
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caution must be used when using the results of this study to inform intervention 
strategies. Significant results from an experimental study could help shape necessary 
prevention and intervention strategies for depression in older PwMS. 
5.5 Directions for Future Study 
While this study has revealed many important findings, it has also set a foundation 
for future research. Future research can focus on examining the differences between the 
prevalence of depression and point-prevalence of depression to see if there are any 
specific factors present at a particular time in one’s life that make one more vulnerable to 
depression.  
One significant aspect of treatment planning that needs further understanding is 
that PwMS continue to struggle with depression and as such, they require constant 
screening and intervention for depression. Due to the overlap of symptoms in MS and 
depression, it is sometimes tricky to skillfully differentiate depression symptoms from 
MS symptoms. Therefore, future research should also inquire how an individual was 
diagnosed with depression by their medical professional. For example, if they received a 
diagnosis based on self-report measures alone, then there may be a possibility that the 
presented symptoms are not an accurate reflection of a mood disorder.  
Future studies can also focus on exploring different aspects of social support in 
older PwMS. For example, perceived social support, utilized social support, number of 
supports, satisfaction with social support and type of social support (e.g., support from 
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spouse versus community members) may give a better understanding of what aspect of 
social support plays a more crucial role in preventing depression in older PwMS. 
As it is a cross-sectional study, causal associations between depression and other 
variables cannot be made. Therefore, one must be careful when interpreting the findings 
and building intervention strategies based on the results of this study. While this study has 
shown that there are relationships between depression, social support, perceived disability 
and physical comorbidities, conclusions cannot be drawn about the direction or time 
sequencing of these connections (e.g., lack of social support and physical disability 
predicted depression, but depression could also predict lack of social support and physical 
disability). At the same time, the presence of other variables such as age and/or gender 
may explain depression and its relationship to social support or perceived disability. So, 
future research may consider the possibility of an experimental design with older PwMS. 
Significant results from an experimental study could help design prevention and treatment 
strategies for older PwMS with depression. 
Future research can focus on evaluating health and lifestyle choices, and their 
interaction with mood which may also be helpful in determining treatment strategies.  
5.6 Conclusion 
 Emerging evidence identifies that depression affects older PwMS and their ability 
to function productively with a chronic illness. The aim of this study was to determine the 
risk factors for depression in older PwMS. Depression and MS share several common 
psychological and neurological symptoms such as fatigue, pain, insomnia, cognitive 
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difficulties, and sleep disturbances which make the diagnosis of depression in PwMS 
difficult for medical professionals. The association established with self-reported 
symptoms of depression and clinical or demographic variables in PwMS may not be only 
because of mood disorders but may also be due to MS. For example, the results of this 
study found that there was a significant relationship between self-reported depressive 
symptoms and age while the relationship between medically diagnosed depression and 
age was not significant. Similar discrepancies were noted in terms of physical disability, 
physical comorbidities, and financial conditions. Therefore, in order to overcome this 
disparity, only those PwMS who had both self-reported symptoms of depression (i.e., 
above HADS-D cut-off) and a medically diagnosed depression formed the depressed 
cohort for the predictive model. The results of the final analysis showed that low social 
support, high perceived disability, and more physical comorbidities were significant 
independent predictors of depression in older PwMS. MS cannot be entirely treated, but 
the symptoms can be managed. However, depression is a treatable condition. Therefore, 
prevention of depression by proper screening techniques, and timely treatment of 
depression can help older PwMS live a productive life even with a chronic condition. 
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Appendix 1 
Variable Coding 
Age 2011 – Year of birth of each participant 
Gender 
Your gender? 
      0: Female 
      1: Male 
 
HADS-D 
Total score on HADS-D 
      0: No Depressive Symptoms (score 0 – 7) 
      1: Depressive Symptoms (score 8 – 21)  
 
Financial Situation 
Which statement best describes your financial situation? 
      1: I have more than enough money to meet my needs so I 
can live 
      2: I have more than enough money to meet my needs so I 
can live 
      3: I have more than enough money to meet my needs so I 
can live 
Recoded: 
      0: Do not have money 
      1: Have money 
 
Type of MS 
What type of MS were you diagnosed with? 
      1: Unknown 
      2: Benign 
      3: Relapsing-Remitting 
      4: Other 
      5: Primary-Progressive 
      6: Secondary-Progressive 
      7: Progressive-Relapsing 
 
The two most frequently reported types: Relapsing-Remitting 
and Primary-Progressive 
Recode (a) 
0. No relapsing-remitting 
1. Relapsing-Remitting 
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Recode (b) 
0. No primary-Progressive 
1. Primary-Progressive 
Early Retirement due to MS 
Did you retire early or have to stop working because of your 
MS? 
      0: No 
      1: Yes 
 
Length of MS 2011 – Year when the participant was diagnosed with MS 
Diagnosis of Depression as 
provided by a Medical 
Professional 
0. No Diagnosis 
1. Diagnosis  
Presence of Depression 
(HADS-D ≥ 8 and 
medically diagnosed 
depression 
0. Non-depressed 
1. Depressed 
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Appendix 3 
Survey Questionnaire 
  
PREDICTORS OF DEPRESSION IN MS 
147 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
PREDICTORS OF DEPRESSION IN MS 
148 
 
 
 
 
PREDICTORS OF DEPRESSION IN MS 
149 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
PREDICTORS OF DEPRESSION IN MS 
150 
 
 
 
PREDICTORS OF DEPRESSION IN MS 
151 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
PREDICTORS OF DEPRESSION IN MS 
152 
 
 
PREDICTORS OF DEPRESSION IN MS 
153 
 
 
PREDICTORS OF DEPRESSION IN MS 
154 
 
 
 
 
 
 
 
 
 
PREDICTORS OF DEPRESSION IN MS 
155 
 
  
PREDICTORS OF DEPRESSION IN MS 
156 
 
 
  
PREDICTORS OF DEPRESSION IN MS 
157 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
PREDICTORS OF DEPRESSION IN MS 
158 
 
 
 
PREDICTORS OF DEPRESSION IN MS 
159 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
PREDICTORS OF DEPRESSION IN MS 
160 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
PREDICTORS OF DEPRESSION IN MS 
161 
 
  
PREDICTORS OF DEPRESSION IN MS 
162 
 
 
  
PREDICTORS OF DEPRESSION IN MS 
163 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
PREDICTORS OF DEPRESSION IN MS 
164 
 
 
 
PREDICTORS OF DEPRESSION IN MS 
165 
 
 
 
PREDICTORS OF DEPRESSION IN MS 
166 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
PREDICTORS OF DEPRESSION IN MS 
167 
 
 
PREDICTORS OF DEPRESSION IN MS 
168 
 
 
 
PREDICTORS OF DEPRESSION IN MS 
169 
 
 
PREDICTORS OF DEPRESSION IN MS 
170 
 
 
PREDICTORS OF DEPRESSION IN MS 
171 
 
 
PREDICTORS OF DEPRESSION IN MS 
172 
 
 
PREDICTORS OF DEPRESSION IN MS 
173 
 
 
PREDICTORS OF DEPRESSION IN MS 
174 
 
 
PREDICTORS OF DEPRESSION IN MS 
175 
 
 
 
PREDICTORS OF DEPRESSION IN MS 
176 
 
 
PREDICTORS OF DEPRESSION IN MS 
177 
 
 
PREDICTORS OF DEPRESSION IN MS 
178 
 
 
PREDICTORS OF DEPRESSION IN MS 
179 
 
 
